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AMP-activated protein kinase (AMPK) is an energy sensor that regulates both 
cellular and organismal energy levels through phosphorylation, leading to the activation or 
inhibition of target proteins. AMPK functions as a heterotrimeric complex consisting of a 
catalytic α subunit and regulatory β and γ subunits. Until recently, research on AMPK was 
based on cell culture studies and the use of non-specific drugs. Since there are multiple 
isoforms of each subunit of AMPK, it was difficult to characterize AMPK’s role due to 
genetic redundancy. In our lab, we identified the first null mutation of the AMPK α subunit 
in the fruit fly, Drosophila Melanogaster. Studying AMPK in fruit flies is somewhat ideal 
since all of its subunit functions and domains are conserved from flies to human and also 
since there are only one gene for each subunit of AMPK, overcoming the redundancy effect. 
 During my graduate study, we have characterized AMPK regulation in three distinct 
aspects. First, we identified AMPK’s role in cell polarity and cell division. We demonstrated 
loss of AMPK activity causes loss of epithelial cell polarity and over proliferation under
 iii 
energetic stress. Second, we characterized AMPK’s role at the whole organism level. 
Reduced AMPK causes hypersensitivity to starvation conditions and this causes a shortened 
life span and higher locomoter activity under energetic stress. In addition, loss of AMPK 
function causes inability to process and store lipids efficiently. Third, we identified a highly-
conserved nuclear export sequence (NES) at the very C-terminal end of AMPKα. We showed 
that the loss of this sequence leads to increased nuclear localization. A transgenic fly 
expressing a truncated copy of AMPKα does not rescue the lethality or neuronal phenotype 
of AMPKα null mutant flies. A truncated copy also shows a reduced phosphorylation rate -- 








      
To my mom and dad, my wife and rest of my family,  











As we all know, graduate school is not an easy road trip. It is a challenging and also a 
rewarding experience. I have been fortunate to be surrounded by people who have helped me 
in this challenging experience. Therefore, I must thank first and foremost to Jay, a mentor in 
every sense of the word. I have learned a lot from him. Thanks to my committee members, 
Franck, Jeff, Manzoor and Steve. They have been the best committee out there. Thanks to 
John and Rob for helping me through the stressful times of my last years. Thanks to Jrgang, 
who is a true friend and has been very helpful with my projects. Thanks to all current and 
former members of Brenman Lab for creating a happy environment for me. Thanks to my 
wife, Sumeyye, for being patient when I had to spend countless hours in the lab. I could not 
be where I am without her support. Thanks to my friend Murat for his support in making the 










TABLE OF CONTENTS 
             
LIST OF TABLES ………………………………………………………………………... viii 
LIST OF FIGURES ………………………………………………………………...………. ix 
CHAPTER 
I Background and Significance………………………...……….…………….1 
                        Introduction ………………………………………………..………………….1 
  References ………………………………………………………………….. 21 
 
II LKB1 and AMPK Maintain Epithelial Cell Polarity Under Energetic  
Stress 
Preface ……………………………………………………………………… 27 
Abstract ………………………………………………...…………………... 28 
  Introduction ………………………………………………………………… 29 
  Materials and Methods …………………………………………...………… 31 
  Results and Discussion ………………………………..…………………… 34 
  References ……………………………………….…………………………. 51 
 
III Altered Starvation Behavior and Reduced Energy Stores Caused by 
Reduced Ampk Function in Drosophila 
Preface ………………………………………………………..…………….. 54 
Abstract ………………………………….…………………………………. 55 





  Experimental Procedures ……………..……………………………………. 59 
  Results ………………………………………………...……………………. 63 
  Discussion ……………………………………………..…………………… 82 
  References ……………………………………………..…………………… 87 
 
IV Identification of A Nuclear Export Signal In The Catalytic Subunit of 
AMP-Activated Protein Kinase 
 
Abstract …………………………………………………….………………. 91 
  Introduction …………………………………………………..…………….. 92 
  Materials and Methods ………………………………………..……………. 95 
  Results ……………………………………………………………..……… 100 
  Discussion ………………………………………………………………… 124 
  References …………………………………………………...……………. 129 
 




LIST OF TABLES 
 
1-1. Protein targets proposed to be phosphorylated by AMPK ……………………….… 16 
ix 
LIST OF FIGURES 
                
1-1. AMPK is a cellular energy sensor.……………………………………...…………… 3 
 
1-2. AMPK subunits domain structure ……………………………………….………….. 7 
1-3. AMPK activation effects glucose and lipid metabolism in liver,  
muscle and adipose tissue …………………………………………………...………13 
 
2-1. Identification of mutations within the single Drosophila ampkα  gene ……………. 35 
2-2. ampkα is required to maintain epithelial polarity under energetic stress ……...…… 39 
2-3. AMPKα activation is not polarized …………………………………………...…… 42 
2-4. LKB1 is required to maintain epithelial polarity under energetic  
starvation conditions …………………………………………………………….…. 44 
 
2-5. The AMPKα-T184D phosphomimetic transgene rescues  
the starvation dependent lkb1 phenotypes …………………………………………. 47 
 
3-1. Expressing either dominant negative AMPKα or RNAi targeting 
 α or γ subunits phenocopies a null allele of the AMPKα subunit …………………. 65 
 
3-2. Reduced expression of the alpha subunit via expression  
of RNAi elements ……………………………………………………….…………. 66 
 
3-3. Reduction of AMPK function causes a reduced lifespan under starvation …...…… 68 
 
3-4. Aging is significantly impacted by altered AMPK function ………………………. 70 
3-5. Locomotor activity and starvation-induced hyperactivity is altered  
as a consequence of reduced AMPK signaling …………………….………………. 72 
 
3-6. Altered feeding behaviors in animals with decreased AMPK function….…………. 74 
3-7. Abnormal lipid accumulation in oenocytes in animals with reduced AMPK ….….. 76 
3-8. Altered metabolism in animals with reduced AMPK function …………………..… 79 
3-9. Rapamycin increases survival rates caused by reduced AMPK function ………….. 81
4-1. AMPKα contains a highly conserved carboxy-terminal tail  




4-2. AMPKα lacking the carboxy terminus localizes predominantly to  
nuclei in vivo and in vitro ………………………………………………….….…... 104 
 
4-3. The carboxy-terminal tail of AMPKα functions as a  
nuclear export sequence (NES) ………………………………………………..….. 109 
 
4-4. Leptomycin B (LMB) treatment, a specific inhibitor of CRM1-mediated  
nuclear export, induces accumulation of AMPKα carboxy tail-containing  
proteins in the nucleus in a time-dependent manner …………………………….... 111 
 
4-5. Previously identified Nuclear Export Sequences (NESs) 
 can substitute for the carboxy-terminus of AMPKα to  
restore cytoplasmic localization ……………………………………………….….. 113 
 
4-6. Truncated AMPKα lacking the carboxy-terminal 23 amino acids  
(AMPKαΔC) associates with β/γ subunits in transfected cells by  
anti-myc immunoprecipitation ………………………………………………...….. 116 
 
4-7. AMPKα, like LKB1, requires Ran-GTP hydrolysis for nuclear import ……….….119 
4-8. Heat shocked transgenic larvae demonstrate increased nuclear 
 localization of AMPKα in vivo ……………………………………….………….. 121 
 
4-9. Phosphorylation of the activation loop threonine (T184) in Drosophila  
AMPKα is reduced in a nuclear enriched form in vivo ………………..…………. 123 
5-1.      Drosophila AMPKγ, Snf4, mutations cause similar phenotype  
             to AMPKα loss in fruit fly sensory neurons……………………………………….142 
 
 CHAPTER I 
Background and Significance 
Introduction 
AMP-activated protein Kinase. All cells require energy to survive. They constantly 
take energy from the environment to sustain ATP levels. Cellular mechanisms, including 
catabolism, provide energy to the cell by converting ADP to ATP. Conversely, most cellular 
reactions use energy by breaking down ATP to ADP, or in some cases ATP to AMP 
(anabolism). What will be the deciding factor for a cell on the catabolism to anabolism ratio? 
Which cellular mechanisms/protein(s) will help cells to maintain energy equilibrium?  
AMP-activated protein kinase (AMPK) is one of the major players sustaining that 
energy equilibrium from yeast to humans. AMPK was first discovered in cell extracts for its 
function of phosphorylating and inactivating the key enzymes of lipid biosynthesis (Haystead 
et al., 1989). In the budding yeast Saccharomyces cerevisiae, the mammalian AMPK 
orthologue SNF1 (Sucrose Non-Fermenting 1) was first discovered from a forward genetic 
screen where mutant yeast strains could not grow on a non-glucose containing media. 
(Celenza and Carlson, 1986). In yeast, SNF1 is essential for the switch from glucose to other 
carbon sources and for the switch from the fermentative/anaerobic to oxidative metabolism 
(Carlson, 1999). In almost every organism, including yeast, worm, fruit flies and all 




AMPK, especially in mammals, is sensitive to the cellular AMP: ATP ratio and is 
activated by a high AMP level or by metabolic stresses that either stimulate ATP usage or 
interfere with ATP production. Stresses such as hypoxia and glucose deprivation will inhibit 
ATP production and biosynthetic pathways; on the other hand, growth and protein 
translation, fatty acid synthesis, activation of motor proteins, ion pumps or channels will 
increase ATP consumption.  
How does AMPK sense the energy level in the cell and react to it? Under normal 
conditions, the cells will keep a low ADP:ATP ratio. An enzyme, adenylate kinase, will then 
catalyze the reaction of 2ADP  ATP + AMP in favor of ADP synthesis and so the 
cellular AMP:ATP level will be lowered and AMPK will stay in an inactive form. When the 
cells are subject to metabolic stresses which interfere with the ATP synthesis or pathways 
that accelerate ATP consumption, then the ADP:ATP ratio will increase and this will cause 
Adenylate Kinase to increase the cellular AMP level and AMPK will become active. As a 
result, AMPK will turn-on catabolic pathways such as increasing fatty acid oxidation and 
glucose uptake and inhibit ATP consuming processes such as synthesis of proteins, fatty 
acids, cholesterol and glycogen. (Fig 1-1) 
AMPK is a Serine/Threonine kinase. Kinases are well-known proteins which regulate 
other proteins and downstream targets by phosphorylating them and thereby inhibiting or 
increasing their activities. AMPK achieves its cellular energy sensor ability by 








Figure from Hardie DG, Review, Nature Reviews, 2007 
Fig 1-1. AMPK is a cellular energy sensor. Under normal conditions the cells maintain a 
high ratio of ATP: ADP. This will cause Adenylate kinase to generate high ADP levels and 
the cellular AMP:ATP level will be low. AMP-Activated protein kinase (AMPK) is therefore 
inactive. When the cells are subject to a metabolic stress that inhibits ATP synthesis, such as 
glucose deprivation or hypoxia, then Adenylate kinase will convert ADP to ATP. This will 
lead to an increased AMP level in the cell, and AMPK will become active. Once active, 
AMPK will balance the energy level in the cell by increasing catabolism and decreasing the 




Does AMPK only sense cellular energy level or does it have any function at the 
organismal level? In recent years, it has been discovered that AMPK is a master regulator of 
food intake. It has been shown that fasting will increase the activity of an isoform of the 
catalytic subunit of AMPK (α2 subunit) in the hypothalamus. On the other hand, an increased 
level of insulin and glucose will decrease AMPK activity in the hypothalamus. Leptin is an 
adipose derived hormone which regulates food intake at the organismal level. Leptin will act 
on the receptors of the hypothalamus and cause a decrease in food intake. It has been shown 
that leptin will inhibit AMPK in the hypothalamus and this inhibition is the key for leptin’s 
anorexigenic effects (Minokoshi et al., 2004). 
AMPK subunits’ structure and regulation. AMPK is a heterotrimeric protein 
complex which consists of catalytic α subunit and regulatory β and γ subunits. To be able to 
have an active AMPK complex, co-expression of all three subunits is required in mammalian 
cells (Woods et al., 1996).  
The α subunit is the kinase and it includes a well-conserved N-terminal Ser/Thr 
kinase domain as well as a conserved Thr172 a. acid that must be phosphorylated for 
activation (Hawley et al., 1996). After being activated by an upstream regulator, the AMPK 
complex will bind to its substrates and transfer the phosphate from ATP to downstream 
targets (Woods et al., 1994). The region C-terminal to kinase domain includes an α helix 
domain which acts as an auto-inhibitory sequence (AIS). Constructs including this C-
terminal region have been found to be 10-fold less active when expressed in bacteria (Pang et 
al., 2007). The AMPKα subunit also has a carboxy terminus domain which is characterized 
as the binding domain of the regulatory β and γ subunits (Iseli et al., 2005) . There are two α 
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subunit isoform genes (α1/α2) in mammals and only one (Snf1) in budding yeast and fruit 
fly, Drosophila Melagonaster.  
The regulatory subunit β acts as a scaffolding protein where it’s C-terminal domain 
bridges the α and γ subunits and forms the AMPK complex. The β subunit is proposed to 
have a central glycogen binding domain where the AMPK complex comes into association 
with glycogen in intact cells (Polekhina et al., 2003). This domain has been co-crystallized 
with β-cyclodextrin, a circular glucan of seven glucose units (Polekhina et al., 2005). A few 
hypotheses as to why AMPK would bind to glycogen exist 1) glycogen synthase is a known 
substrate of AMPK, so proximity might dictate the interaction, or 2) AMPK senses the 
cellular glycogen/energy level and reacts to it using its glycogen binding domain. There are 
two β subunit isoform genes (β1 and β2) which exist in mammals and three in the budding 
yeast, whereas fruit flies have only one β subunit. 
The AMPKγ subunit includes 4 conserved 60 a. acid tandem repeats named after their 
discoverer Bateman as CBS motifs (first found in the enzyme cystathionine β -synthase) 
(Bateman, 1997) and variable N-terminal regions. Currently, the function of the N-terminal 
regions is not known. A short sequence immediately preceding this N-terminal region is 
involved in binding to the β subunit (Viana et al., 2007). On the other hand, the well-
conserved 4 CBS motifs will act as pairs to form two Bateman domains which act as 
nucleotide binding sites. AMP and ATP will compete to bind these regions and regulate their 
activity level. Mutations in these regions will reduce AMP binding, suggesting they are 
binding sites for nucleotides. In addition, ATP will bind to these regions with a mutually 
exclusive manner to AMP but with five-fold lesser affinity than AMP binding, explaining 
how a low level of total cellular AMP can compete with a high level of ATP in the cell (Scott 
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et al., 2004). There are three AMPKγ subunit isoform genes (γ1, γ2, and γ3) which exist in 




























Figure from Hardie DG, Review, Nature Reviews, 2007 
Figure1-2. AMPK subunits domain structure. The size of each subunit is drawn to scale 
and the same color domains consist of related sequences. Since the mammalian α1/ α2 and 
β1/ β2 are similar, only one example is drawn. The α domain consists of the kinase domain, 
including the upstream phosphorylation site and autoinhibitory sequence (AIS) and a C-
terminal region for β and γ subunit binding. The β subunit includes a C-terminal α and γ 
subunit binding site and proposed central glycogen-binding domain. The γ subunits have a 
short region for β subunit binding and four conserved CBS motifs that bind as pair and form 
Bateman domains. AMP and ATP compete to bind these domains and regulate the activity of 
AMPK complex.     
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How is the activity of AMPK regulated? In mammalian cells, a high AMP level 
activates AMPK but this has not been demonstrated convincingly in lower eukaryotes like 
the budding yeast. In mammals, AMP activates AMPK by three distinct mechanisms. First, 
as is mentioned above, AMP binding to CBS domains in the γ subunit will activate the kinase 
domain in the α subunit. Second, AMP binding will cause Thr172, a residue in the kinase 
domain necessary for activation, to be phosphorylated by an upstream regulator (Hawley et 
al., 2003). Third, AMP binding will inhibit the dephosphorylation of Thr172 by the protein 
phosphatases PP2A and PP2C (Davies et al., 1995). There is also recent work suggesting 
AMP, rather than increasing both the phosphorylation of Thr172 and inhibiting the effects of 
protein phosphatases at the same time, is most essential for keeping the AMPK complex 
active (Sanders et al., 2007). In any case, all of these mechanisms combined cause more than 
a 1000-fold increase in the kinase activity (Suter et al., 2006). All of the activation effects of 
AMP are antagonized by AT, thus, proving AMPK acts as a cellular energy sensor. 
AMPK activity regulation by the upstream kinases. AMPK must be 
phosphorylated at Thr172 by an upstream regulator to become active. In yeast, three 
upstream kinases (Sak1, Elm1 and Tos3) have been demonstrated to phosphorylate AMPK 
by in vitro and in vivo studies (Hong et al., 2003; Sutherland et al., 2003). In mammalian 
systems, there are no orthologue of the yeast upstream kinases but there are three kinases that 
are closest in sequence to the yeast kinases. One of them is LKB1 which has been identified 
as a major upstream regulatory kinase for AMPK and activates AMPK with the help of the 
regulatory subunits, STRAD and Mo25 (Woods et al., 2003). LKB1 is a tumour suppressor 
gene with mutations in this gene leading to an inherited human cancer, Peutz-Jegher 
Syndrome (Alessi et al., 2006). Although LKB1 must be bound to two regulatory subunits to 
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be functionally active, its kinase activity is constitutive and independent of the AMP level in 
the cell (Lizcano et al., 2004).  
In cells lacking LKB1, like HeLa cells (tumor cells lacking LKB1), there is still some 
AMPK activity and Thr172 phosphorylation can be increased by adding Ca+2 to the medium. 
It is identified now that under those conditions, AMPK will be phosphorylated by an 
additional upstream kinase, Ca/Calmodulin-dependent protein kinase kinase (CaMKK) 
(Hurley et al., 2005). The ability of CaMKK to activate AMPK indicates that under certain 
paradigms where increased cytosolic Ca+2 is present, AMPK might be activated without a 
requirement for a change in AMP level. On the other hand, increasing cytosolic Ca+2 often 
increases ATP-demand, i.e., Ca+2 has to be actively pumped back out of the cytosol. 
Furthermore, CaMKK is only expressed in certain sub-types of cells, especially neurons, but 
LKB1 is expressed ubiquitously. 
Activators of AMPK. Since metabolic stresses diminish ATP levels, they activate 
AMPK regardless of their cause. One of these stresses is exercise, which will activate AMPK 
depending on the intensity level (Winder and Hardie, 1996). It will cause this effect not only 
in skeletal muscle, but also in liver and adipose tissue (Kelly et al., 2004). It is well known 
that exercise reduces the risk of developing many diseases including Type 2 diabetes and 
obesity, and AMPK may play a role preventing these diseases. This hypothesis was 
confirmed by the discovery that the Type II diabetes drug metformin indirectly activates 
AMPK (Zhou et al., 2001). 
Furthermore, stresses such as glucose deprivation, hypoxia, oxidative stress and 




In recent years, hormones that are secreted by the adipose tissue have been 
discovered, and these hormones regulate processes such as glucose and lipid metabolism, 
whole body weight regulation, and etc. (Friedman and Halaas, 1998). Leptin is one of these 
hormones; regulating food intake and body weight. Leptin will increase fatty acid oxidation 
and glucose uptake (Kamohara et al., 1997) in non-adipose tissues and will prevent them 
from a functional impairment known as “lipotoxicity” (Minokoshi et al., 2002). Although 
many of leptin’s downstream effects are through activation of the Jak-Stat signaling pathway 
(Rosenblum CI, Endocrinology, 1996), in recent years leptin has been found to 
phosphorylate and activate AMPKα2 in skeletal muscle (Minokoshi et al., 2002). 
Adiponectin is another molecule that is secreted by adipocytes to increase glucose uptake and 
fatty acid oxidation, and thereby inhibit gluconeogenesis (Goldstein and Scalia, 2004). 
Adiponectin will regulate these effects by stimulating AMPK phosphorylation in skeletal 
muscle and liver since blocking AMPK activity by a dominant-negative mutant of AMPK 
also blocks these effects (Yamauchi et al., 2002).  
Downstream targets of AMPK and its effects on cellular mechanisms. AMPK 
was first discovered in mammalian cells as the kinase that phosphorylated, and thereby 
inactivated, the two main enzymes of lipid biosynthesis, acetyl-CoA carboxylase (ACC), 
which regulates fatty acid synthesis, and 3-hydroxy-3-methylglutaryl-CoA reductase (3-
HMG-CoA reductase), which regulates cholesterol synthesis (Haystead et al., 1989). The 
direct downstream targets of AMPK which have been identified to date include more than 20 
proteins. In each case, either a Ser or Thr residue is phosphorylated, i.e., a classic 
serine/threonine kinase (Weekes et al., 1993).  
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In addition, there are numerous downstream targets of AMPK which have been 
identified in various tissues and through in vitro studies using the AMPK activator 5-
aminoimidazole-4-carboxamide (AICA) riboside. 
Regulation of lipid metabolism. Using AICA riboside, a nucleoside which when taken 
into cells is converted into the AMP analogue ZMP, it has been shown that increased AMPK 
activity causes phosphorylation and inactivation of acetyl-CoA carboxylase and HMG-CoA 
reductase activity in hepatocytes.  Inactivation of these enzymes specifically halts fatty acid 
and sterol synthesis (Corton et al., 1995). Furthermore, in skeletal muscle AMPK will 
phosphorylate ACC and inhibit the enzyme. The level of malonyl-CoA will decrease causing 
an inhibition of fatty acid synthesis. This set of events will lead to a stimulation of fatty acid 
oxidation and thereby catabolism (Merrill et al., 1997). 
Regulation of glucose metabolism. AMPK will regulate glucose metabolism by 
stimulating glucose uptake through translocation of the glucose transporter Glut4 to the 
plasma membrane in skeletal muscle (Kurth-Kraczek et al., 1999). Once the glucose is 
accumulated in the muscles, AMPK will phosphorylate and inhibit glycogen synthase. The 
glycolysis rate will then increase (Jorgensen et al., 2004).  
In the liver under fasting conditions, glucagon will stimulate glucose release from the 
liver by stimulating transcription of gluconeogenesis genes. When cellular ATP levels are 
low, AMPK will be activated and attenuate gluconeogenesis by phosphorylating and 
inhibiting the nuclear translocation of TORC2 (Koo et al., 2005). Monocytes, immune 
system cells, mostly function in the damaged tissue area under hypoxic conditions. To be 
able to function properly, monocytes use glycolysis as their energy source. AMPK has been 
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shown to increase the level of glycolysis in monocytes by phosphorylating inducible 6-
phosphofructo-2-kinase (iPFK-2) under hypoxic conditions (Marsin et al., 2002). 

























Figure from Towler and Hardie, Review, Circulation Research, 2007 
 
 
Figure 1-3. AMPK activation effects glucose and lipid metabolism in liver, muscle and 
adipose tissue. The thick arrows show pathways stimulated by AMPK. Thos inhibited are 
shown by thin arrows with thick bars across them. Pyruvate oxidation through AMPK is 
mediated by upregulation of mitochondrial biogenesis. Fatty acid oxidation through AMPK 
is mediated by phosphorylation of ACC2 and increased fatty acid entry into mitochondria, in 







Regulation of growth and cell division. AMPK also regulates cell growth and 
proliferation processes since these pathways require immense amounts of energy. In mouse 
embryonic fibroblasts, AMPK acts as a cellular energy sensor and the deprivation of glucose 
will cause activation of AMPK. This will cause phosphorylation of p53 and entry into G1-S 
cell cycle arrest (Jones et al., 2005). AMPK activated by AICA ribose inhibits the growth of 
cancer cells by increasing expression of p53 and other cyclin dependent kinases (Rattan et 
al., 2005). 
Under energetic stress, AMPK will inhibit protein synthesis by inhibiting the activity 
of mTOR, a regulator of the initiation steps of protein synthesis (Proud, 2004). mTor is 
regulated by the TSC1-TSC2 complex and the Ras–related G protein, Rheb. AMPK will 
achieve its goal through phosphorylation and activation of the TSC1-TSC2 heterodimer. 
When AMPK phosphorylates TSC1-TSC2, the complex will inhibit Rheb by its GTP-ase 
activity. Rheb will not then be able to activate mTor (Inoki et al., 2003). On the other hand, 
insulin-like growth factor 1 (IGF1) will activate Akt. Akt will phosphorylate the TSC1-TSC2 
complex at different sites. This will prevent Rheb inhibition and mTor will be activated 
(Inoki et al., 2002). Furthermore, hepatocytes are the main tissue in liver that are responsible 
for protein synthesis and storage. Incubating hepatocytes under low oxygen conditions cause 
AMPK activation and phosphorylation of elongation factor (eEF2), leading to the inhibition 
of its activity. This effect leads to inhibition of protein synthesis (Horman et al., 2002). 
In summary, in mammals AMPK activation decreases the expression of genes 
involved in lipogenesis and gluconeogenesis in liver. As mentioned above, this will increase 
glucose transport and fatty acid synthesis in muscle cells. In addition to phosphorylation of 
many targets, AMPK will also achieve some of these functions by regulating transcription 
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factors. For instance, in muscle cells mitochondrial biogenesis is essential for adaptation to 
chronic energy deprivation. AMPK has been shown to increase mitochondrial biogenesis 
under such stresses. AMPK will increase activation of the transcription factor PPARγ 
(peroxisome proliferator activated receptor γ) co-activator 1-α (PGC1-α), a key regulator of 
mitochondrial biogenesis (Zong et al., 2002). A summary of all these and other downstream 















             Table 1-1 
 
Table from Hardie DG, Review, Nature Reviews, 2007 
             Table 1-1. Protein targets proposed to be phosphorylated by AMPK.
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AMPK’s role in diseases 
AMPK and obesity, diabetes and metabolic syndrome. Type II diabetes is caused 
by increased glucose in the plasma due to insulin resistance with obesity known to increase 
the risk of developing Type II diabetes. Since the activation of AMPK decreases 
gluconeogenesis in the liver and increases glucose uptake by muscle and other tissues, the 
activation of AMPK might help to decrease plasma glucose levels. In addition, insulin 
resistance causes accumulation of fatty acids in the liver and muscle even though these 
tissues don’t have high amounts of mitochondrial oxidative capacity (Lowell and Shulman, 
2005). Since AMPK increases fatty acid oxidation and increase mitochondrial biogenesis and 
decreases fatty acid synthesis, AMPK might decrease the high level of fatty acids in those 
tissues.  
AMPK activation can reverse the risk of developing metabolic syndrome since it can 
decrease high levels of glucose and fatty acids in plasma and other tissues -- decreasing the 
risk of obesity. Consistent with these observations two of the main Type II diabetes drugs, 
e.g., metformin, are shown to indirectly activate AMPK in vitro (Fryer et al., 2002; Zhou et 
al., 2001). Later, it was demonstrated in the liver that metformin lowers plasma glucose 
levels entirely through the LKB1/AMPK pathway (Shaw et al., 2005).  
In addition, exercise is an effective way of preventing insulin resistance and obesity 
and some of these effects are through the activity of AMPK. Furthermore, the use of the 
AMPK activator, A-769662, has led to: the reversal of insulin resistance and glucose 
intolerance, lower plasma lipid and free fatty acids levels, and reduced body weight in ob/ob 




AMPK and Cancer. LKB1 is major upstream regulator of AMPK and a tumor 
suppressor gene. LKB1 mutations cause Peutz-Jeghers syndrome where the loss of LKB1 
leads to polyp formation in the intestine (Hemminki et al., 1998). AMPK is upstream of the 
cell growth and cell division protein mTor and therefore regulates cell proliferation and 
autophagy. Activation of AMPK in cancer cells causes growth arrest in these cells through 
activation of p53 and cyclin-dependent kinase inhibitors (Rattan et al., 2005). Furthermore, a 
number of studies point out both obesity and Type II diabetes are associated with an 
increased risk of cancer and mortality (Dossus and Kaaks, 2008). AMPK’s protective effect 
from obesity and Type II diabetes could help protect from tumor onset. On the other hand, 
AMPK has a role in cell survival under energetic stress. p27 is a cell cycle regulator 
(Massague, 2004) which also regulates cell survival through autophagy (Wu et al., 2006). 
AMPK is known to regulate p27 phosphorylation and its stability; leading to cell survival 
under metabolic stress instead of cell-death (Liang et al., 2007). This could very well explain 
why tumor cells persist under metabolic stress conditions and their resistance to 
chemotherapy. Further information is needed to define AMPK’s role in cell growth/division 
and in cell survival and cancer biology. 
AMPK and heart disease. As mentioned above, AMPKγ subunits contain 4 CBS 
motifs that form two Bateman domains where AMP and ATP bind and regulate the AMPK 
complex. The AMPKγ subunit has received much more attention since some hereditary 
dominant mutations of AMPKγ2 have been shown to lead to heart disease in humans (Arad 
et al., 2007). Two of these mutations R531Q and R384T are not inherited and cause death 
due to heart failure and/or respiratory problems during the first few months of infancy in 
humans (Burwinkel et al., 2005). Most of these mutations cause ventricular pre-excitation, a 
  
 19 
condition called Wolff-Parkinson White syndrome (WPW Syndrome). The other symptoms 
include: cardiac hypertrophy, excessive cardiac glycogen, preexcitation, and supraventricular 
arrhythmias. These dominant mutations are either in the CBS motifs or at the linker domains 
between the CBS motifs and demonstrated to inhibit AMP-binding and lead to reduced 
AMPK activity (Daniel and Carling, 2002). 
AMPK identified from a forward genetic screen. In the Brenman lab, a forward 
genetic screen was performed using Drosophila Melagonaster as an assay organism. To 
perform this assay, the Gal4-UAS system has been used to express actin fused to GFP in the 
peripheral nervous system (PNS) neurons. Using an alkylating agent, EMS, random 
mutations were introduced into the fly genome and then characterized when the mutations 
were homozygous lethality. For the homozygous lethal mutations, any mutation displaying a 
morphological defect in the dendrites, axons and/or filopodia of the PNS were retained and 
characterized further. Through this method, 13 different mutations were isolated (Medina et 
al., 2006). Two were chosen to study in greater detail, one was a gene termed capulet on the 
2nd chromosome, and the other was located on the X chromosome, later discovered to be the 
AMP-Activated Protein Kinase α subunit. There were two different alleles isolated that were 
both mutation of AMPKα with both giving rise to the same phenotype in the PNS neurons. 
One of the alleles caused an amino acid substitution, S211L, which was located within the 
conserved region of the kinase domain. The other isolated mutation caused an amino acid 
change, Q295STOP that leads to a truncation. The phenotype and lethality of the flies were 
rescued either by reintroducing a wild-type copy of the gene or through the reintroduction of 




AMPK is highly conserved among organisms. It is essential to know that the gene 
of study is conserved among species, especially when you are studying an invertebrate, 
Drosophila Melagonaster, as your assay system. After identifying the first AMPKα mutation 
in fruit flies, conservation among organisms was checked. The AMPKα kinase domain is 
highly conserved between yeast to Drosophila (72%) and between Drosophila to humans 
(96%)(Lee et al., 2007). The function of AMPK as a cellular energy sensor, phosphorylation 
by upstream kinases including LKB1, and the regulatory subunits β and γ are all conserved 
from yeast to fruit flies to humans. 
Rationale of Studies. Most of the research on AMPK is based on in vitro studies of 
isolated cultured cells and the use of non-specific drugs.  Due to the genetic redundancy for 
each subunit of AMPK in mice, in vivo functions in multicellular animals have been difficult 
to identify. Mouse mutants of either AMPKα1 or AMPKα2 are viable and have no obvious 
defects while the double knockout of the AMPKα mouse dies in early stages (~embryonic 
9.5)(personal communication B. Viollet). For these reasons, studying AMPK function 
genetically in Drosophila is an excellent approach. It should also be noted there is no 
functionally redundancy for any of the three AMPK subunits, i.e., one gene for every subunit 
of AMPK in fruit flies. In Drosophila the AMPK complex has not been characterized to date, 
other than some in vitro studies on S2 cells.  In addition, there is also a lack of detailed 
localization studies for AMPK. With numerous genetic and cell biological reagents we have, 
and that we can generate, we should be able to better understand the in vivo function of 
AMPK in Drosophila. For instance, by generating transgenic flies, it is easier to express the 
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In this chapter, I helped in the characterization of AMPKα null mutants. In addition, I 
generated the transgenic fly that overexpresses the constitutively active (T184D) version of 
AMPKα. We mapped the lines to the chromosome and crossed them to lkb1 null mutant flies. 
Overexpression of this transgene rescued the loss of epithelial polarity due to the lkb1 null 
mutant. 
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LKB1 and AMPK maintain epithelial cell polarity under energetic stress 
Abstract 
LKB1 is mutated in both familial and spontaneous tumours, and acts as a master 
kinase that activates the PAR-1 polarity kinase, and the Adenosine 5’monophosphate-
activated kinase, AMPK. This has led to the hypothesis that LKB1 acts as a tumour 
suppressor because it is required to maintain cell polarity and growth control through PAR-1 
and AMPK respectively. However, the genetic analysis of LKB1-AMPK signaling in 
vertebrates has been complicated by the existence of multiple redundant AMPK subunits. 
Here, we describe the identification of mutations in the single Drosophila AMPK catalytic 
subunit, AMPKα. Surprisingly, ampkα mutant epithelial cells lose their polarity and over-
proliferate under energetic stress. LKB1 is required in vivo for AMPK activation and lkb1 
mutations cause similar energetic stress-dependent phenotypes to ampkα mutations. 
Furthermore, lkb1 phenotypes are rescued by a phosphomimetic version of AMPKα. Thus, 
LKB1 signals through AMPK to coordinate epithelial polarity and proliferation with cellular 





LKB1 is a serine threonine kinase that is mutated in most cases of Peutz Jeghers 
Syndrome, an autosomal dominant disorder in which patients develop benign harmatomas 
and a high frequency of malignant tumours (Alessi et al., 2006). Furthermore, LKB1 is also 
mutated in some sporadic cancers, such as 30% of lung adenocarcinomas, and the expression 
of the kinase is also down-regulated in a significant proportion of breast cancers (Sanchez-
Cespedes et al., 2002). In both cases, tumours associated with LKB1 mutations usually 
derive from epithelial tissue. LKB1 is a master kinase that can potentially activate a number 
of downstream kinases by phosphorylating a conserved threonine in their activation loops 
(Lizcano et al., 2004). Two of these kinases have been extensively characterized: PAR-
1/MARKs (microtubule affinity-regulating kinases) and AMPK (AMP-activated protein 
kinase). PAR-1 regulates cell polarity in numerous cell types and organisms (Benton and St 
Johnston, 2003; Bohm et al., 1997; Cohen et al., 2004; Kemphues et al., 1988; Shulman et 
al., 2000). AMPK acts as a cellular energy sensor, since it is activated by AMP, which 
accumulates when ATP levels are low(Kahn et al., 2005). AMPK then mediates the cellular 
response to energetic stress by activating energy-producing activities, while inhibiting 
energy-consuming ones, such as translation and proliferation. LKB1 regulates both cell 
polarity and cell growth and division in cell culture and in vivo (Baas et al., 2004; Kemphues 
et al., 1988; Martin and St Johnston, 2003; Narbonne and Roy, 2006; Tiainen et al., 1999). 
One hypothesis envisions LKB1-signaling mediated through PAR-1 regulating cell polarity 
while LKB1-signaling through AMPK could control cell growth and proliferation. However, 
recent cell culture experiments suggest that AMPK also plays a role in the polarization of 




2007). Here, we show that LKB1 and AMPK are required to maintain epithelial polarity and 
integrity under energy-limiting conditions in Drosophila. These results therefore provide a 
potential mechanism to coordinate the regulation of cell polarity and proliferation with 























Materials and methods 
Mutant characterization. An EMS mutagenesis screen on the X-chromosome was 
performed as previously described (Medina et al., 2006).  Early second instar larvae were 
visually screened for dendritic defects using fluorescent microscopy. The ampkα mutants 
were mapped to approximately 150 kb on the X-chromosome using a molecularly defined 
deficiency, Df(1)Exel6227, an undefined deficiency, Df(1)AD11, and a duplication of the Y-
chromosome, Dp(1;Y) / Df(1)svr. Predicted coding regions for genes in the region were 
sequenced using PCR amplicons made from mutant genomic DNA and one gene (AMPKα; 
CG3051; NM_057965) was discovered that had significant mutations in all three alleles.   
Construction of AMPKα transgenes. The wild type AMPKα transgene was cloned 
into the pUAST vector (Brand and Perrimon, 1993) as an EcoRI-BglII fragment of an EST, 
corresponding to AMPKα-RA transcript (www.flybase.org). The mCherry-AMPKα fusion 
protein was made using an mCherry construct (kindly provided by Roger Tsien, University 
of California, San Diego) at the amino-terminus fused in-frame to AMPKα into the pUAST 
vector. The phosphomimetic-activated form of AMPKα (AMPKα T184D) was made by 
PCR-based site directed mutagenesis converting base C549 to G549. The transgenes were 
introduced into a w1118 stock by P-element-mediated transformation. 
Fly stocks and crosses. AMPKα alleles were recombined with FRT101 for mitotic 
recombination. Other mutant stocks used are FRT82B, lkb4A4-2 and FRT82B, tend. 
UAS:Cherry-AMPKα and UAS:GFP-LKB1 were expressed in follicle cells using the Cy2-
Gal4 driver. Flip out experiments were performed by crossing UAS:Cherry-AMPKα and 
UAS:AMPKα-T184D to y, w, hs:Flp; tub-FRT-cc-FRT-Gal4, UAS:GFP and heat-shocking 




w; UAS:AMPKα-T184D/CyO; FRT82B, Ubi:nlsGFP and y, w, hs:flp; da:Gal4, 
FRT82B,lkb14A4-2 /TM3,Sb. 
Starvation conditions and clone induction. Adult flies were placed in vials 
containing “normal” Drosophila food media (5% glucose, 5% yeast extract, 3.5% wheat 
flour, agar 0.8%), energetic starvation medium (1% yeast extract, 3.5% wheat flour , agar 
0.8%), or specific nutrient starvation medium (5% glucose, agar 0.8%). Clones were induced 
by heat-shocking adult females at 37°C for 2 hours on two consecutive days. Females were 
dissected 2 days after the last heat-shock.  
Staining and imaging procedures. Immunofluorescence on ovaries was performed 
using standard procedures. Primary antibodies were used as follows: rat anti-DECad (1/1000) 
(Oda et al., 1994); mouse anti-Crb (cq4) (1/50, Developmental Studies Hybridoma Bank); 
Guinea pig anti-Cora (1/2000) (Fehon et al., 1994); rabbit anti-aPKC (1/500, Sigma); rat 
anti-Baz (1/500) (Wodarz et al., 1999), mouse anti Dlg (1/50, Developmental Studies 
Hybridoma Bank); rabbit anti-Dg (1/1000) (Deng et al., 2003), rabbit anti- phospoT385-
AMPK (1/100, Cell Signaling). Actin staining was performed with Rhodamine-conjugated 
phalloidin (Molecular Probes, Oregon). Second instar larvae were dissected in 4% 
paraformaldehyde as previously described (Medina et al., 2006). Secondary antibodies 
coupled with Cy5 (anti-rabbit and anti-guinea pig) or Texas-Red (anti-mouse and anti-
rabbit)(Jackson ImmunoResearch, 1/500). Images of follicle cells were done on a Biorad 
Radiance 2000 confocal microscope with a Nikon Plan Fluor 40X (NA 1.3) objective using 
Lasersharp software. Live animal images of dendrite morphology were acquired using a 
Zeiss LSM 510 confocal microscope by exciting the 488-nm argon-line to excite GFP. 




Fisher Scientific Pittsburgh, PA) to restrict movement, but not cause bursting of the body 
wall. Images were taken using a Pan-Neofluar 40X/1.3 oil immersion lens with a 2µm optical 
slice and Zeiss LSM Imaging software. Images were sized and cropped with Adobe 























Results and Discussion 
AMPK contains three protein subunits - α, β, and γ - that form a heterotrimer. The α-
subunit (AMPKα) encodes a highly conserved serine-threonine kinase, while the other 
subunits are regulatory. From a Drosophila forward genetic screen for mutants affecting 
larval neuronal dendrite development (Medina et al., 2006), we identified several lethal 
mutations in AMPKα. The EMS mutants, ampkα 1 and ampkα2, contain a single amino acid 
change (S211L (completely conserved)) and a pre-mature stop codon (Q295 STOP), 
respectively, while ampkα 3 has a 16 base pair deletion creating a stop codon (Y141 STOP) 
(Fig. 2-1A). All ampkα mutants, homozygous or in trans with a deletion covering the locus, 
displayed a completely penetrant and nearly identical phenotype, with greatly enlarged 
plasma membrane domains in dendrites, but not in axonal compartments (Fig. 2-1C, and data 
not shown). In addition, ampkα1 and ampkα3 could be rescued to viability with either a 
chromosomal duplication carrying a Wild-type ampkα allele, a wild type AMPKα transgene, 
or a transgene that is tagged with the red fluorescent protein mCherry (Fig. 2-1D and 
Methods). The requirement for ampkα is cell-autonomous, since transgene expression within 
only neurons rescues the phenotype (Fig. 2-1D). These mutations therefore represent the first 
knockouts of the single AMPKα catalytic subunit in the Drosophila genome, and allow the 











Figure 2-1: Identification of mutations within the single Drosophila ampkα  gene.  
A) Schematic domain representation of AMPKα and corresponding genetic lesions in 
mutants. The Serine-Threonine kinase domain (black, amino acids 39-280) and T-Loop 
(grey, amino acids 167-194) are shown with the sites of mutations, S211L, Q295STOP and 
Y141STOP for ampkα1 ampkα2 and ampkα3, respectively. (B) Representative image of wild 
type da neurons expressing an Actin::GFP-fusion transgene in a 2nd instar larva. (C) ampkα 
mutants display enlarged plasma membrane domains (arrows) in sensory neuron dendrites 
but not axons. (D) A wild type ampkα transgene expressed autonomously within da neurons 
completely rescues the dendrite phenotype. (B-D) Background genotypes are w; 






While ampkα mutants display a strong phenotype in larval neuronal dendrites, no 
phenotype was observed in early larval lkb1 mutants (data not shown), probably due to the 
large maternal contribution of this protein. In order to explore the relationship between 
AMPKα and LKB1 function without the confounding issues caused by the differing maternal 
contributions of each protein, we chose to examine follicle cells of the Drosophila ovary. The 
follicle cells that surround the oocyte have a typical epithelial architecture with a highly 
polarized actin cytoskeleton, in which the apical surface is marked by dense actin bundles in 
the apical microvilli, the lateral cortex is covered by a thin actin mesh, and the basal side 
contains a prominent network of parallel actin stress fibers. This polarized organization of 
actin typifies many epithelia, including the main mammalian tissue culture model for 
polarized epithelial cells, MDCK cells (Fievet et al., 2004). We did not observe any actin 
phenotypes in ampkα3 mutant follicle cells using standard detection procedures (Fig. 2-2A). 
Since AMPK is maximally activated under low cellular energy levels, we also tested the 
influence of energy stress by strongly reducing the availability of sugar in the Drosophila 
culture medium. Under these conditions ampkα3 mutant cells display a strong actin 
phenotype (Fig. 2-2A). The density of basal stress fibers is strongly reduced, whereas the 
amount of apical F-actin increases. This phenotype is highly penetrant under these starvation 
conditions (98%, n=49) and is also observed with the two other alleles of ampkα.  
Since this phenotype reflects a disruption of the apical-basal polarity of the actin 
cytsokeleton, we examined other polarity markers within these cells. ampkα mutant clones 
induced in adult flies fed with high sugar diets did not show any polarity phenotypes, 
consistent with the absence of an actin phenotype under these conditions (Fig. 2-2A). Under 




polarity. Apical markers, such as atypical Protein kinase C (aPKC) and Crumbs (Crb) lose 
their cortical localization completely and appear to be down-regulated, as do the lateral 
markers Discs-large (Dlg) and Coracle (Cora) (Fig. 2-2A). In contrast, Dystroglycan (Dg), 
which is normally enriched at the basal cortex, extends into the lateral domain, and 
occasionally even reaches the apical membrane (Fig. 2-2A). This suggests that the phenotype 
represents an expansion of the basal domain at the expense of the lateral and apical domains. 
Although most aspects of apical-basal polarity are completely disrupted in ampkα 
mutant clones under energetic stress, E-Cadherin (ECad) is usually still enriched at the 
adherens junctions, suggesting that the altered polarity is not a secondary consequence of a 
loss of intercellular adhesion. The sub-apical localization of Bazooka (Baz) with Cadherin is 
also maintained in most cases (Fig. 2-2B). This indicates that Bazooka is not in a complex 
with aPKC in columnar follicle cells, but is instead associated with the adherens junctions, as 
has recently been described in the Drosophila embryo and in neuroepithelial cells of the 
zebra fish neural tube (Afonso and Henrique, 2006; Harris and Peifer, 2005).  
A significant proportion of ampkα mutant clones show a more severe phenotype, in 
which the cells round up and lose their epithelial organization to form multiple layers of cells 
(Fig. 2-2B). In these cases, Baz is now also absent from the cell cortex. Finally, larger mutant 
clones, particularly at the anterior or the posterior of the egg chamber, show a complete loss 
of epithelial organisation and over-proliferate to form small tumour-like growths (Fig. 2-2C).  
As one proposed function for AMPK is to sense and maintain cellular ATP levels, the 
polarity phenotype observed under starvation conditions could be due to low cellular ATP 
concentrations. To test this hypothesis, we examined cells mutant for tenured (tend). Tend 




intracellular ATP concentrations to levels sufficient to maintain cell survival and growth but 
not cell division (Mandal et al., 2005). This cell cycle block is believed to require AMPK 
activation. In agreement with a role for Tenured in cell cycle progression, we did not 
observed tend clones bigger than four to six cells under energetic starvation conditions (Fig. 
2-2D). In contrast to ampkα mutant cells, however, tend mutant cells showed no polarity 
defects, ruling out the possibility that the ampkα phenotype is a secondary effect of low ATP 
levels. We also tested the effect of specific nutrient starvation, by feeding flies only glucose, 
but these conditions did not induce any polarity phenotypes in ampkα mutant cells (Fig. 2-
2E). Thus, AMPKα is specifically required to maintain epithelial polarity and growth control 























Figure 2-2: ampkα  is required to maintain epithelial polarity under energetic stress. 
A)  ampkα3 mutant follicle cell clones under normal (left) or energetic stress conditions 
(right). Mutant cells are marked by the absence of GFP (green). Markers are indicated to the 
left; F-Actin (red), Discs large (Dlg, red, ), atypical Protein Kinase C (aPKC, blue), Crumbs 
(Crb, red), Coracle (Cora, blue), DEcadherin (ECad, red) and Dystroglycan (Dg, blue). The 
apical domain is at the top and faces the oocyte, which also contains a layer of cortical actin 
(top panels).   
B) ampkα3 clone stained for DNA (blue) and Bazooka (Baz, red). Baz is usually present at 
the apical domain of mutant cells, but is lost in the most severely-affected clones that lose 
their epithelial organization and form multiple layers.  
C) ampkα 3 clone stained for DNA (blue) and Discs Large (Dlg, red). Large ampkα 3 clones 
at the anterior or posterior poles of the egg chamber over-proliferate to form tumour-like 
structures composed of unpolarized cells.  
D) tenured (tend) mutant cells stained for aPKC (blue) and Dlg (red) . Cells maintain normal 
epithelial polarity.  
E) ampkα 3 clone from a female fed on a glucose only diet stained for aPKC (blue) and Dlg 
(red). These conditions of protein and lipid starvation do not affect the polarity of ampkα 3 
mutant cells. 







Since our results indicate that ampkα plays a role in epithelial polarity, we assessed 
whether the localization of the protein itself is polarized. We also examined LKB1 
localization, as it is a potential regulator of AMPK. Transgenic wild type fusion proteins for 
both AMPKα and LKB1 rescue lethal null mutants to viability, and should therefore mimic 
the localizations of the endogenous proteins. LKB1-GFP is mainly found at the apical and 
lateral cortex of the follicle cells, and is absent from the basal domain (Fig. 2-3A). This basal 
exclusion is surprising, as cortical localization of LKB1 requires its membrane targeting by 
prenylation of a conserved CAAX motif (Martin and St Johnston, 2003). This suggests that 
the lipid composition of the basal domain is different from the rest of the plasma membrane 
and/or that LKB1 post-translational modifications are asymmetrically controlled. In contrast, 
mCherry-AMPKα does not show any enrichment or asymmetric localization at the plasma 
membrane, and is found distributed throughout the cytoplasm, but absent from the nucleus 
(Fig. 2-3A). The localization of LKB1 suggests that AMPK could be activated specifically at 
the apical and lateral cortices of the cells. To test this hypothesis, we used an antibody 
against the LKB1 phosphorylation site of AMPK (Phospho-T184). The immunostaining is 
reduced to background levels in both ampkα and lkb1mutant clones. This confirms the 
specificity of the antibody and indicates that LKB1 is the principle AMPK kinase in these 
cells (Fig. 2-3B). In wild-type cells, PhosphoT184-AMPK is found diffusely in the 
cytoplasm (Fig. 2-3B). The effect of AMPK on apical-basal polarity is therefore not related 









Figure 2-3: AMPKα  activation is not polarized. 
A) Follicle cells expressing Cherry-AMPKα (left) and GFP-LKB1 (right).  
B) Wild-type follicle cells (green) adjacent to ampkα 3 (left ) or lkb14A4-2 (right ) mutant cells 








Since LKB1 activates AMPK, we wondered if similar phenotypes could be observed in 
lkb1 mutant cells. lkb1 clones can lead to severe polarity defects in follicle cells in normally 
fed flies (Martin and St Johnston, 2003). However, these defects are observed only in large 
clones that are induced before the follicular epithelium forms from the somatic stem cells, 
and small lkb1 mutant clones, induced after the formation of the epithelium, have no effect 
on follicle cell polarity or the organization of the actin cytoskeleton (n=24) (Fig. 2-4A). This 
suggests that LKB1 is required for the establishment of epithelial polarity in well-fed flies, 
but not for its maintenance, as is the case for PAR-1 (Doerflinger et al., 2003). In contrast, 
under conditions of glucose starvation, small lkb1 clones that were induced after the 
formation of the follicular epithelium show a fully penetrant polarity phenotype (100%, 
n=21). Under these conditions, we observed a loss of the polarized localization of Dlg, 
aPKC, Crb and Cora (Fig. 2-4A). However, Baz distribution is usually not affected by lkb1 
loss of function (data not shown). Dg extends laterally and occasionally localizes to the 
apical domain (Fig. 2-4A). The actin cytoskeleton is also disturbed with more F-actin 
apically and a decreased density of stress fibers on the basal side. Finally, large lkb1 clones 
lose their epithelial organization completely and over-proliferate to form small neoplasms 
(Fig. 2-4B and C). Thus, lkb1 mutant cells exhibit identical phenotypes to ampkα mutant 
















Figure 2-4: LKB1 is required to maintain epithelial polarity under energetic starvation 
conditions. 
A) lkb14A mutant follicle cell clones under normal (left) or  energetic stress conditions 
(right). Mutant cells are marked by the absence of GFP (green) and visualized with 
the same markers (at left) as described in Figure 2-2. 
B) lkb1 4 clone stained for DNA (blue) and Discs Large (red, left panel) or DECad (red, 
right panel). Large mutant clones at the anterior or posterior poles of the egg chamber 


















Since lkb1 and ampkα mutant clones lead to very similar polarity defects and LKB1 
phosphorylates AMPKα, we wondered if a constitutively active form of AMPKα could 
rescue the lkb1 phenotype. We therefore generated transgenic lines carrying a UAS-AMPKα 
construct, in which Threonine184 is replaced by an Aspartate, which should mimic the 
activating phosphorylation of this site by LKB1 (Lizcano et al., 2004). The expression of the 
AMPKα-T184D transgene in lkb1 mutant clones fully rescues their starvation-dependent 
polarity and over-proliferation phenotypes (n=37), whereas the Gal4 driver alone has no 
effect (Fig. 2-5). Furthermore, AMPKα-T184D-expressing mutant clones also have a normal 
actin cytoskeleton (100%, n=13) (Fig. 2-5). Thus, the phosphomimetic version of AMPKα 




















Figure 2-5: The AMPKα-T184D phosphomimetic transgene rescues the starvation 
dependent lkb1 phenotypes. lkb1 mutant cells marked by the absence of GFP (green) 
expressing the UAS-AMPKα-T184D transgene. The expression of the phosphomimetic 
AMPKα transgene (T184D) rescues the lkb1 energetic stress dependent phenotypes as 
indicated by the normal distribution of various polarity markers (indicated to the left or right 
of the panels). Top: F-actin and DECad (red); DG (blue). Bottom: Dlg and Crb (red) aPKC 










The recovery of null mutations in ampkα has allowed the first in vivo analysis of 
AMPK function in a multicellular organism, which has revealed an unexpected role for the 
kinase in the maintenance of epithelial polarity under conditions of energetic stress. This 
implies that at least one of the pathways that normally maintain cell polarity cannot function 
when cellular energy levels are too low, and that AMPK activation compensates for this 
defect. Therefore, this new function of AMPK may underlie that it is a priority for epithelial 
cells to maintain their polarity even when they are under stress conditions. 
A surprising feature of the ampkα polarity phenotype is that it has opposite effects on 
the actin cytoskeleton and the cortical polarity cues. In mildly affected clones, basal actin is 
strongly reduced, with a corresponding increase in the amount of apical actin.  In contrast, 
mutant clones show an expansion of the basal markers into the lateral and apical regions, and 
a loss of lateral and apical markers. Thus, the effects on actin may be independent of other 
polarity defects, suggesting that AMPK acts though different pathways to regulate actin and 
cortical polarity in opposite ways. 
It is unclear how AMPK regulates the actin cytoskeleton, but it is possible that it acts 
on only one side of the cell and that the reciprocal changes on the other are caused by a 
change in the concentration of free G-actin or an actin nucleator, as has been shown for abl 
mutants during cellularization (Grevengoed et al., 2003). For example, loss of AMPK could 
increase actin polymerization apically, thereby depleting the pool of free actin that can 
polymerize basally. Alternatively, ampkα mutants may prevent the formation of basal actin 





The cortical polarity defects of ampkα mutant clones also suggest a reciprocal 
relationship between the basal and apical/lateral membrane domains, since the basal domain, 
marked by Dystroglycan, is dramatically expanded, whereas the determinants for the lateral 
domain (Discs large) and the apical domain (aPKC and Crumbs) disappear from the cortex. 
This suggests that there is some form of mutual antagonism between the basal and lateral 
domains that maintains a sharp boundary between them, as has been described for apical and 
lateral domains through the inhibitory phosphorylation of Bazooka (PAR-3) by lateral PAR-
1, and of PAR-1 by apical aPKC (Benton and St Johnston, 2003; Suzuki et al., 2004). If this 
model is correct, AMPK could be required to restrict the extent of the basal domain, with the 
expansion of this domain in ampkα mutants leading to the exclusion of lateral and apical 
markers. Indeed, the over-expression of Dystroglycan has been found to cause a similar loss 
of apical and lateral markers to that seen in ampkα clones (Deng et al., 2003). Alternatively, 
AMPK could be necessary to maintain the localization of the apical and lateral determinants, 
which in turn prevent the basal domain from extending into these regions.  
Mutations in AMPK not only disrupt the polarity of the follicle cell epithelium, but also 
cause the cells to over-proliferate, giving rise to a tumorous phenotype. One possible 
explanation for this phenotype is that it is caused by the mislocalization and down-regulation 
of Dlg. Dlg is a member of a class of tumour suppressors in Drosophila that also includes Lgl 
and Scribble, and follicle cell clones mutant for any of these genes over-proliferate to form 
invasive tumours that are similar to those formed by ampkα and lkb1 clones under low 
energy conditions (Bilder and Perrimon, 2000; Goode et al., 2005; Hariharan and Bilder, 
2006). Furthermore, the tumour suppressor function of these proteins is probably conserved 




target of the papilloma virus E6 oncoprotein (Nagasaka et al., 2006; Takizawa et al., 2006). 
This may account for the observation that AMPK is required to trigger the G1/S checkpoint 
under conditions of energetic stress (Mandal et al., 2005). However, it has also been shown 
in mammals that AMPK activates TSC2 to repress the Insulin/TOR pathway, and therefore 
functions as a tumour suppressor that inhibits cell growth and division (Inoki et al., 2005; 
Inoki et al., 2003). Loss of this repression might therefore provide an alternative explanation 
for the overgrowth of ampkα mutant clones. 
Although the molecular pathways involved remain to be elucidated, our results 
demonstrate that ampkα mutant cells lose their polarity under low energy conditions and 
over-proliferate to give rise to tumour-like growths. The activation of AMPK depends on its 
phosphorylation by LKB1, and loss of LKB1 produces an identical tumorous phenotype. 
Thus, the novel functions of AMPK reported here may provide a basis for the tumour 
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In this chapter, I generated the transgenic flies that overexpress the dominant negative 
copy of AMPKα. Then, we did initial studies of hypersensitivity to starvation stress. I 
performed the initial studies of lipid accumulation in the liver-like oenocytes cells (Gutierrez 
et al.,2007). I performed the characterization of the neuronal phenotypes of the dominant 
negative AMPKα and RNAi γ constructs.   
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Altered starvation behavior and reduced energy stores caused by reduced 
AMPK function in Drosophila Melagonaster 
 
Abstract 
Organisms must utilize multiple mechanisms to maintain energetic homeostasis in the 
face of limited nutrient availability. One mechanism involves activation of the heterotrimeric 
AMP-activated protein kinase (AMPK), a cell-autonomous sensor to energetic changes 
regulated by ATP to AMP ratios. We examined the phenotypic consequences of reduced 
AMPK function, both through RNAi knockdown of the gamma subunit (AMPKγ) and 
through expression of a dominant negative alpha (AMPKα) variant in Drosophila 
melanogaster. Reduced AMPK signaling causes hypersensitivity to starvation conditions as 
measured by altered lifespan and locomotor activity. Locomotor levels in flies with reduced 
AMPK function were lower during unstressed conditions, but significantly higher than wild 
type during starvation-induced hyperactivity, an adaptive response to encourage foraging. 
Unexpectedly, total dietary intake was greater in animals with reduced AMPK function yet 
total triglyceride levels were lower.  AMPK mutant animals displayed starvation-like lipid 
accumulation patterns in metabolically key liver-like cells, oenocytes, even under fed 
conditions, consistent with a cellular starvation phenotype. Measurements of O2 consumption 
reveal that metabolic rates were greater in animals with reduced AMPK function.  Lastly, 
rapamycin treatment reduces the starvation sensitivity of animals with reduced AMPK 
function. Collectively, these results are consistent with models that AMPK shifts energy
56 
usage away from expenditures into a conservation mode during nutrient-limited conditions at 
a cellular level. The highly conserved AMPK subunits throughout the Metazoa, suggest these 
findings may provide significant insight into phenotypic outcomes of pharmacologically 
























The precise mechanisms of how organisms maintain energetic homeostasis in light of 
dynamic food availability remains largely unknown.  A molecule thought to represent a 
central cellular mechanism mediating energy allocation is the AMP-activated protein kinase, 
by virtue of its activation by the end product of ATP hydrolysis (Winder and Thomson, 
2007).  Activation of AMPK by AMP leads to the phosphorylation of Acetyl CoA 
carboxylase (ACC) and the Peroxisome Proliferator Activated Receptor (PPAR), which has 
the net biological effect of diverting energy away from cellular processes that require energy 
and towards a conservation or energy production mode (Long and Zierath, 2006).  The 
functional AMP-activated protein kinase (AMPK) is a heterotrimer consisting of a catalytic 
alpha (α), a regulatory gamma (γ), and a scaffolding beta subunit (β) (Riek et al., 2008). In 
mammals, multiple genes encode each of the subunits, which form different heterotrimeric 
complexes (Birk and Wojtaszewski, 2006), so despite intense scrutiny of the roles of AMPK 
in mammals, the complete organismal context of AMPK function remains poorly understood. 
In Drosophila, a single gene encodes each subunit, and clear homologs of each subunit are 
present and display 60%, 62%, and 62% identity with human α, β, and γ subunits, 
respectively. Drosophila AMPK is highly similar to mammalian AMPK, as it is formed via a 
heterotrimeric complex, is activated by AMP, and has many of the same targets, including 
acetyl-CoA carboxylase (ACC) (Pan and Hardie, 2002). 
 Genetic modulation of AMPK activity in various model systems suggests that 
AMPK may represent an underlying mechanism to increase longevity as a consequence of 
dietary restriction (Greer and Brunet, 2009), and also that AMPK activity may be responsible 




targeting AMPK activity have been developed as therapeutics for treatment of human 
pathologies associated with diabetes (Viollet et al., 2009).  
We report here that attenuated AMPK function in Drosophila leads to a series of 
behavioral and metabolic phenotypes demonstrating these animals behave as though they are 
experiencing chronic starvation.  Specifically, animals deficient in AMPK signaling show a 
hypersensitivity to starvation conditions, altered activity levels, and differential lipid 
quantities and distributions.  These phenotypes further demonstrate a pivotal role of the 
AMPK molecule in the organization of behavioral and physiological responses to nutrient-






Drosophila cultures and stocks. The AMPKK57A transgene was generated by a 
mutagenic PCR strategy and cloned into the UAS-vector for embryo transformation.  The 
UAS-AMPK-α WT transgene was previously described (Mirouse et al., 2007).  Other lines 
that were employed in this study were Ubi-GAL4, Act5C-GAL4, hsp70-GAL4, 109 (80) 
GAL4, UAS-alpha RNAi, UAS-gamma RNAi, UAS-LSD2-GFP and the UAS-dcr 2.  The 
UAS-dcr2 and UAS-LSD2-GFP lines were kind contributions from Dr. Paul Taghert and 
Ronald Kuhnlein respectively.  All other lines, with the exception of the Ubiq-GAL4 and 
AMPK alpha transgenes were procured from the Bloomington Stock center (Bloomington, 
IN).     All flies were maintained in an incubator maintained at 25° C and under a 12:12 LD 
cycle.  Flies were cultured on a standard molasses-malt-cornmeal-agar-yeast medium and 
housed in uncrowded conditions. All transgenes were backcrossed to the w1118 background.  
For hsp70-GAL4 lines, we raised and maintained animals at 19° C for all assays (uninduced), 
and induction was carried out by placing animals at 30° C for 1 hr twice daily for three days, 
and then assaying animals at 25°C.   
Lifespan Measurements. Measurements of lifespan have been widely employed in 
Drosophila as a metric of stress sensitivity (e.g, Broughton et al., 2005; Hector et al., 2009).  
We placed thirty 3 to 5 day old mated flies (males and females housed separately) in vials 
with a two percent agar solution to starve the animals.  We assessed percent survival of at 
least three replicate vials twice daily.  For each vial, we assessed the median survival for the 
treatment and data were pooled to estimate a mean median survival and then employed a 
one-way ANOVA with post-hoc Tukey’s comparison for differences between 




Locomotor measurements. Locomotor activity was monitored with a TriKinetics 
Locomotor Monitor (Waltham, MA) on the aggregate population of thirty 3-5 day old flies 
(Zhao et al., 2010).  Flies were housed in a 12:12 LD cycle for three days prior to the 
experiments.  Flies were transferred to a vial containing starvation or normal medium at ZT0.  
Total beam counts were monitored continuously through an automated system.  For analysis 
of the starvation-induced component, we chose to examine only the first 12 hours of 
locomotor activity, as significant numbers of AMPK deficient flies would die after 12 hours 
and confound interpretation.  We determined the amount of activity during starvation relative 
to the activity of fed conditions for the same time period.   
Triglyceride and Oil Red O Measurements. Total triglyceride levels were assessed 
through use of a Serum Total Triglyceride Kit (Sigma, St. Louis) according to 
manufacturer’s instructions and as previously described (Zhao et al., 2010).  Thirty flies were 
weighed, and homogenized completely in 0.5 mL 100mM Tris-HCl (pH 7.4), 1 NaCl, 1% 
TritonX-100 buffer.  Homogenates were centrifuged for 2 minutes at room temperature at 
13000 x g to collect particulates.  One hundred microliters of supernatant was transferred to a 
96 well plate and an equal volume of working triglyceride reagent was added to each well.  
Triplicate wells were performed for each sample and three replicate samples of flies were run 
for each treatment condition.  Absorbance at 510 nm wavelength was measured on a Perkin 
Elmer Victor III multilabel microplate reader.  Absorbance values were compared to 
standards and normalized by fly weight.  Homogeneity of slopes test was performed 
following linear regression on normalized triglyceride levels to compare different genotypes 
following starvation conditions. Oil Red O staining was done as described (Gutierrez et al., 




paraformaldehyde in PBS to expose the oenocytes, and then fixed for 10 minutes.  After 
rinsing twice with water, lipid droplets were stained with a 0.06% Oil Red O solution in 60% 
isopropanol for 30 minutes at room temperature, and then rinsed three times with water. 
 Stained larvae were then mounted in glycerol and visualized on a light microscope. 
Feeding Assays. To assess food intake, we employed the CAFE assay (Ja et al., 
2007), which quantifies dietary intake using a volumetric capillary feeder.  We placed three 
3-5 day old adult flies in the CAFE chamber and monitored the dietary intake of either 5% 
sucrose/5% yeast extract or 5% sucrose media.  Red food coloring was added to each diet to 
facilitate measurements.  Mineral oil was placed over the top of the capillary to reduce 
evaporation. Animals were placed in a 12:12 LD cycle at ZT0 (lights on).  Humidity was 
controlled by placing the chamber over a water source.  Animals were then transferred the 
following day and capillary tubes were marked and measured.  We also determined the 
amount of diet that was lost to evaporation by placing a capillary feeder in a chamber without 
flies and this value was subtracted from the values determined for the feeding experiments.  
Males and females were housed in separate chambers.  Differences in dietary intake were 
assessed using a Two-Way ANOVA.   A complementary group of experiments employed 
variations in a two-choice assay (Al-Anzi et al., 2006).  This assay was developed to assess 
aversion to various stimuli and relies on scoring of an impregnated dye in the food and 
subsequent scoring of abdominal color.  High numbers of scored individuals are predicated 
on a period of starvation, so we modified the number of scored individuals on a single dye in 
the food with variations in food access.  
For rapamycin (LC Laboratories, Woburn MA) feeding, 200 adult Drosophila were 




rapamycin to lay eggs overnight.  Larvae were scored (n>200 for all conditions) on days 5 
and 7 after egg laying and scored for the absence or presence of the green fluorescence of the 
FM7i balancer.  Mutant survival percentages were normalized to their survival at 5 days 
without rapamycin (but vehicle alone).  For adult rapamycin feeding, adult animals were 
placed on instant Carolina medium containing 100 uM rapamycin for three days prior to 
starvation assays. 
Oxygen Consumption measurements. A calibrated 50uL micropipette was flame 
bent to fashion a micromanometer.  Whatman filter paper was saturated in a KOH solution, 
to act as a CO2 scavenger, and placed in the bottom of a 15 mL polypropylene tube.  Loose 
cotton was placed over the KOH-saturated filter paper, and 10 flies were loaded into the 
chamber which was then sealed with wax.  Water was delivered to the end of the 
micromanometer and given ten minutes to equalize.  After this time period, the position of 
the meniscus was marked and re-marked following a ten minute period for three replicates of 
ten minutes to estimate an average reading.   Measurements were taken on two genotypes 
differing in AMPK function at the same time; since manometric readings may be influenced 
by external factors such as changes in barometric pressures, and these grouped readings were 
repeated six times were analyzed for statistical significance using a nested ANOVA 






Altered AMPK function causes abbreviated lifespan during starvation. To 
investigate the roles of AMPK in the maintenance of metabolic homeostasis in adults, we 
relied on two experimental strategies to alter AMPK activity.  The first approach was to 
generate a dominant negative construct (K57A), in which the catalytic domain of the alpha 
subunit was altered to inactivate the ATP binding domain, as suggested by a number of 
studies in mammalian systems (Woods et al., 2000; Nagata et al., 2009).  As a 
complementary approach, we genetically introduced a double-stranded RNA species 
targeting the gamma subunit (γRNAi).  A null mutation in the alpha subunit of AMPK has 
been shown to cause lethality in late larval stages (Mirouse et al., 2007).  
Expression of the K57A variant with the Act5C-GAL4 driver completely 
phenocopies the lethality associated with the null mutant, as did specific RNAi constructs 
targeting the gamma subunits (data not shown).   Thus, employing this ubiquitous and strong 
driver to express elements aimed at reducing AMPK expression or function results in a 
phenocopy of the lethality caused by a null mutant.  Furthermore, the larval lethality caused 
by the null mutant was not rescued by expression of this dominant negative construct, but 
was rescued by a wild-type alpha transgene (data not shown). In early larval stages, the null 
mutant causes aberrant morphology of the Class IV multi-dendritic neurons (Mirouse et al., 
2007).   Using the 109(2)80-GAL4 driver, we specifically expressed the K57A alpha variant 
in these sensory neurons, which results in similar morphological defects (Figure 3-1A-F), 
indicating that this element is effective at genetically reducing AMPK function in a manner 
similar to loss of function mutations. Consequently, we refer to this variant as the AMPKDN 




subunit in animals expressing either an RNAi targeting the γ  (γRNAi) or α (αRNAi) 
subunits, and observed a significant reduction in the α protein levels in these two genotypes 
but not in animals possessing the GAL4 alone or in animals expressing an RNAi targeting a 

























Figure 3-1. Expressing either dominant negative AMPKα  or RNAi targeting α  or γ 
subunits phenocopies a null allele of the AMPK α  subunit. Representative confocal 
images from animals specifically expressing an actin-GFP construct in class IV multi-
dendritic sensory neurons in larval Drosophila, with different levels of AMPK function.  (A) 
Normal dendritic morphology of animals with wild-type AMPK.  (B) Dendritic morphology 
in animals with an AMPKα subunit null mutation (Mirouse et al., 2007): note the large 
varicosities on neuronal dendrites.  (C) Animals expressing the dominant negative alpha 
subunit variant which phenocopies the null mutant, showing the same abnormal varicosities 
(white arrows). (Scale bar = 10µm) (D) Animals expressing an RNAi targeting the alpha 
subunit also phenocopies the null mutant, but with smaller varicosities (E) Inset of D. F. 
Animals expressing RNAi targeting the gamma subunit also, but more weakly, phenocopies 







Figure 3-2. Reduced expression of the alpha subunit via expression of RNAi elements. 
Western blot for the AMPK alpha subunit from lysates from different genotypes, some 
expressing RNAi for either the alpha (second lane) or the gamma subunit (third lane).  
Compared to animals possessing the driver alone (first lane) or an unrelated gene (ATG8) 
(fourth lane), there was significantly less expression of the alpha subunit standardized to 










Having validated that these genetic strategies were producing phenotypes consistent 
with reduced AMPK activity, we then asked whether attenuated AMPK function would alter 
sensitivity to metabolic challenges.  We tested the progeny of a UAS-AMPKDN under the 
control of a Ubiquitin-GAL4 (Ubiq) driver for survival during starvation, and found a 
significant reduction of lifespan as compared to a similar cross using a wild-type alpha 
sequence (which only differs in one amino acid) or to parental stocks (Figure 3-3A, C).  This 
driver recapitulates the global expression pattern of the ubiquitin gene, but is not as strong as 
the Act5C-GAL4 driver (Schulz et al., 2001). Reduced viability during adult starvation was 
also evident in animals expressing an RNAi line specifically targeting the gamma subunit 
also under the control of the Ubiq driver (Figure 3-3B, D).  We also assessed aging in these 
animals and found a significant reduction in lifespan under nutrient-rich conditions (Figure 3-
4), although reduced AMPK function did not significantly impact lifespan for younger 
cohorts used for starvation studies.     
Given the developmental defects exhibited in animals lacking functional AMPK, we 
performed experiments to exclude developmental defects that could be caused by impaired 
AMPK function as a contributor to starvation sensitivity in adults.  We therefore employed 
the hsp70-GAL4 element, which allows temporal control through stage-specific induction by 
heat-shock and thus avoid any developmental disturbances caused by earlier transgene 
expression.  Comparison of the median survival of animals experiencing different heat-
shock-induced AMPK impairment in adult stages still demonstrated significant reduction in 
















Survival curves from adult females (A) and males (C) expressing either one or two copies of 
the AMPKDN transgenes under the control of the Ubiq-GAL4 driver.   Expression of these 
transgenes reduced lifespan compared to the parental controls or animals expressing a wild-
type α subunit.  Survival curves of adult females (B) and males (D) expressing an RNAi 
element targeting the gamma subunit. The lifespan of these animals was significantly shorter 
than the parental lines or the w1118 genetic background control (p< 0.05, ANOVA).  (E) 
Female and (F) male adult induction of the AMPK-interfering transgenes significantly 
reduces median lifespan (* indicate significant differences between non-induced (unfilled 























Figure 3-4. Aging is significantly impacted by altered AMPK function.  We measured 
percent survival daily from males and females either expressing the dominant negative or 
wild type α subunit under normal fed conditions.  Overexpression of the α subunit leads to 
increased longevity as compared to w1118 (the genetic background) and in contrast expression 









Reduced AMPK causes changes in locomotor activity. Starvation induces 
hyperactivity in Drosophila and other Metazoa, and is believed to be an adaptive response, as 
elevated activity promotes increased foraging (Isabel et al., 2005; Lee and Park, 2005).  
Given the profound nature of the sensitivity to starvation in animals with reduced AMPK 
function, we hypothesized that a potential mechanism of such sensitivity may be a greater 
level of hyperactivity. The rationale is that accelerated activity would have the net effect of 
more rapid exhaustion of energy stores.  We first evaluated normal locomotor activity levels 
in animals with reduced and wild-type AMPK.  Animals expressing the dominant negative 
AMPK α transgene or γ RNAi had significantly lower amounts of locomotion during normal, 
unstressed conditions as compared to animals expressing a wild-type AMPK α subunit or to 
w1118 genetic background controls (Fig 3-5A) (ANOVA – Tukey posthoc comparison P< 
.001).  However, while wild-type animals show a steady increase in activity levels as a 
function of starvation duration, animals expressing the dominant negative AMPK transgene 
or the gamma RNAi element displayed instantaneous elevated activity levels (Figure 3-5B, 














Figure 3-5. Locomotor activity and starvation-induced hyperactivity is altered as a 
consequence of reduced AMPK signaling. Locomotor activity measured during fed (black 
line) and starved conditions (gray line) in female animals (A) expressing the wild-type α 
subunit (left), the dominant negative α transgene (middle), and the γ RNAi element (right).  
Quantification of total locomotion during fed conditions (B) and the magnitude of starvation-
induced hyperactivity (C).  Measurements of locomotor activity were initiated at ZT0 (lights 
on) and flies were maintained in a 12:12 LD (light-dark) cycle (shaded and dark bars).  (B) 
Expression of either the α dominant negative or the γ RNAi element lead to reduced 
locomotor activity during the fed state (ANOVA, P< 0.05).  (C) Both the γ RNAi element 
and the α dominant negative variant caused greater levels of starvation-induced activity 




Reduced AMPK causes hyperphagia. Since the loss of AMPK function causes 
exaggerated responses to starvation, we speculated that this may be caused by reduced food 
intake.  Further rationale comes from mammalian studies where AMPK activity has been 
shown to regulate the expression of orexigenic transmitters (Claret et al., 2007). To test this 
hypothesis, we measured total dietary intake employing the CAFE assay (Ja et al., 2007).  
Total daily food intake was significantly increased in animals expressing the AMPKDN or 
AMPK gamma RNAi variant and this increase was evident, independent of nutritional value 
(Figure 3-6A).  Specifically, in both males and females, total dietary intake was nearly twice 
that of animals with wild-type AMPK function (P < 0.0001, F = 29.09, Two-Way ANOVA). 
This implicates that not only are animals with reduced AMPK function actively feeding, but 
that they also display hyperphagia. This hyperphagia might be caused by a persistent 
starvation signal/phenotype.  To test whether loss of AMPK leads to altered hunger-driven 
feeding behavior, we scored individuals for incorporation of blue dyed food in the abdomens.  
A variation of this assay was originally developed to assess whether compounds were 
aversive or appetitive, and require a period of starvation to achieve significant numbers of 
individuals that feed enough to facilitate scoring (Al-Anzi et al., 2006).  We reasoned that if 
animals deficient in AMPK were consistently starved, then higher rates of scored individuals 
would be attained without prior starvation conditions.  Consistent with these predictions, we 
found that animals expressing the dominant negative AMPK construct incorporated the dye 
at a higher level (62.2 %) compared to animals with wild-type AMPK function (37.7 %). 
Notably, comparable numbers of individuals were scored following a period of starvation, 







Figure 3-6.  Altered feeding behaviors in animals with decreased AMPK function.  
(A) Daily food intake in adult Drosophila with different AMPK functional levels with a 
sucrose diet (left) or a yeast-sucrose diet (right).  Males and females showed no difference in 
food intake and data was pooled.  Six trials consisting of three trials each were measured for 
one day.  Asterisks denote statistical significance (ANOVA, p< 0.05) compared to all other 
genetic controls. 
(B) Abdominal scoring in animals expressing either a wild-type or the dominant negative 
alpha subunit following either 12 hours of fed conditions (grey bars) or starvation (black 
bars).  Numbers in boxes represent the total number of flies scored for a particular genotype.  
Animals were given two hours of exposure to the food with the dye and then anaesthetized 






Abnormal lipid accumulation phenotypes caused by altered AMPK. Animals 
with reduced AMPK function demonstrate hypersensitivity to starvation, despite also 
displaying hyperphagia, suggesting that these animals are persistently experiencing 
starvation.  Because AMPK null mutants die as larvae and that these larvae are 
characteristically smaller than wild-type larvae of the same age (J.E. Brenman, personal 
observations), we speculated that persistent starvation may be the ultimate cause of reduced 
larval growth and lethality.   We took advantage of previous observations that starvation 
induces an accumulation of lipid droplets in larval oenocytes (Gutierrez et al., 2007), and 
consequently, we examined whether oenocytes from animals with reduced AMPK would 
show aberrant oenocyte lipid accumulation phenotypes.  We introduced a lipid marker: 
LSD2-GFP, (Gronke et al., 2003) in larvae with either wild-type AMPK function or lacking 
AMPK alpha gene function (Mirouse et al., 2007).  Under fed conditions, animals with wild-
type AMPK function showed little to no lipid droplets present in oenocytes as expected and 
previously published (Gutierrez et al., 2007), whereas in contrast, larvae lacking AMPK 
showed significantly more droplets and larger droplets per cell, resembling the starved 
phenotype of wild-type oenocytes (Figure 3-7).  This phenotype was also evaluated using 
Oil-O-red staining which independently labels lipid droplets and circumvents over-
expression of the LSD2-GFP marker, yet similar patterns were still observed (Figure 3-7A-
G), specifically, that oenocytes with reduced AMPK function show significant lipid 













Figure 3-7.  Abnormal lipid accumulation in oenocytes in animals with reduced AMPK. 
Oenocytes in the larva are a specialized cell type that functions similar to mammalian liver 
and accumulates lipids during starvation (Gutierrez et al., 2007).  We introduced a LSD2-
GFP fusion to oenocytes to observe the size and quantity of lipids in oenocytes in genetic 
backgrounds differing in AMPK function.  In wild-type animals under fed conditions, the 
LSD2-GFP labeled lipid droplets were small and not prominent (A), whereas in the starved 
state, both the size and number of lipid droplets increase (C).  In contrast, in AMPKα 
deficient larvae, there was no difference between the fed and starved states (B and D) and 
these closely resemble the starved state of wild-type animals.  This phenotype was also 
exhibited in animals expressing the dominant negative AMPK subunit in oenocytes (E).  
Likewise, the amount of Oil-O red staining was notably absent in wild-type animals during 
fed conditions (F) but labeled significantly more droplets in animals lacking AMPK function 














Altered metabolism in animals with reduced AMPK function. Given these 
observations of persistent starvation phenotypes, we then next tested to see if the size of 
stored energy reserves were impacted in animals with attenuated AMPK function.  We 
quantified triglyceride levels in animals with either mutant or wild-type AMPK function 
during normal and starvation conditions. While there were no overt differences in weight, 
there was a significant impact of the AMPKDN on total triglyceride stores under fed 
conditions; with the average amount of triglyceride levels for the dominant negative being 
significantly lower than AMPK-wild type expressing flies (Figure 3-8A).  Thus, the 
decreased amounts of triglyceride stores in flies with altered AMPK function, correlates with 
abbreviated lifespan during starvation.   
 While this observation might explain shortened survival under energetic stress, lower 
triglyceride levels resulting from a loss of AMPK function contradicts previous reports that 
activation of AMPK causes reduced triglyceride turnover (Zang et al., 2004).  However, this 
result is consistent with a previous observation in C. elegans demonstrating that AMPK 
mutants do not properly utilize lipid stores during energetic stress (Narbonne and Roy, 2009).  
In attempts to reconcile these observations, we hypothesized that reduced triglyceride levels 
concomitant with hyperphagia may be caused by increased metabolic demand present in 
animals with reduced AMPK function.  If this were the case, then we reasoned that these 
animals might exhibit higher consumption of oxygen. Measurements of O2 consumption in 
animals expressing the dominant negative alpha construct were consistently higher than in 
animals expressing a wild-type alpha subunit (P< 0.0002, F = 47.07, Repeated Measures 











Figure 3-8.  Altered metabolism in animals with reduced AMPK function.  We 
quantified total triglyceride levels in adult females with different levels of AMPK function 
(A).  Animals expressing the dominant negative construct under the control of the Ubiq-
GAL4 driver show significantly lower triglyceride levels during fed conditions (Time 0). We 
also tested oxygen consumption in animals expressing either the dominant negative or a 
wild-type alpha subunit (B).   Animals expressing the dominant negative have higher O2 






Rapamycin alleviates AMPK phenotypes. Given the observations that animals with 
reduced AMPK function have higher metabolic rates, we tested the hypothesis that this 
metabolic activity may stem from failures to reallocate energy during nutritional stress. 
AMPK signaling can intersect with the target of rapamycin (TOR); AMPK activation would 
lead to TOR inhibition, which would lead to decreased protein synthesis and decreased 
energy consumption. (Dowling et al., 2010). We fed rapamycin, a TOR inhibitor, to larvae 
possessing the null allele of the α subunit and tested if this agent impacted the lethality 
associated with this mutation.  We identified that the majority of AMPK deficient larvae died 
between the fifth and seventh day of the third instar, but that rapamycin increased the 
percentage of mutant larvae surviving to the seventh day (Figure 3-9A).  We next tested 
whether rapamycin would likewise improve the starvation sensitivity in adult animals with 
reduced AMPK function.  The median survival of these animals significantly improved 
during starvation conditions for females (P=0.003 T-Test) and males (P=0.0005 T-Test) 

















Figure 3-9.  Rapamycin increases survival rates caused by reduced AMPK function. (A) 
We fed AMPKα mutant larvae rapamycin and evaluated survival.  The majority of the lethal 
effects of the AMPKα mutation occur during the 5th and 7th day of the third instar.  
Incorporation of rapamycin reduced this lethality during this timeframe.  (B) Likewise, 
rapamycin feeding for three days prior to starvation improved survival of adult animals 





We report that animals with reduced AMPK function are highly susceptible to the 
effects of starvation, and note significant changes in behavioral and physiological responses 
to starvation caused by altered AMPK function.  Demonstrations of increased hyperactive 
locomotor responses, lower triglyceride levels, increased hunger-driven feeding behaviors, 
higher metabolic rates, and lipid accumulation phenotypes in liver-like oenocytes indicate 
that the loss of AMPK leads to a persistent starvation signal both at the organism and cellular 
levels.   
These phenotypes suggest mechanisms underlying reduced survival during starvation 
in animals with altered AMPK activity. For example, starvation normally induces 
hyperactivity in flies with wild-type AMPK function (Isabel et al., 2005; Lee et al., 2005), 
and we observed larger hyperactive responses which occurred more rapidly in animals with 
reduced AMPK function.  Hyperactive responses require more energy than rest but under 
normal conditions in the wild, might lead to increased foraging behavior and obtainment of 
new food sources.  However, in cages without food in the laboratory, hyperactivity leads to 
diminished ability to withstand nutritional stress as increased energy expenditure is not offset 
by obtainment of new food sources.  In addition, reduced triglyceride storage found in 
animals with reduced AMPK function further limits the ability to provide fuel for such 
energy-requiring responses.  Similarly, oenocytes are thought to be involved in the 
processing of fats making them ready for utilization by the organism (Gutierrez et al., 2007), 
suggesting that accumulation of lipids in oenocytes in AMPK mutants could be linked to the 




We suspect that many of these starvation phenotypes are consequences of a core 
metabolic defect. While we cannot rule out potential pleitropic effects, we suggest our results 
are consistent with an idea of compensatory changes in critical physiologies and behaviors 
stemming from defects in energy allocation, storage, or utilization. Our observations that 
rapamycin significantly extends lifespan, and that animals with reduced AMPK function 
consume more oxygen indicate inabilities to appropriately regulate cellular metabolic 
activities.  Our observations are also consistent with multiple observations that AMPK is an 
important factor regulating cellular activities, and regulates expenditures of energy including 
protein synthesis (Deshmukh et al., 2008).  Furthermore, similar observations have been 
made regarding AMPK function in the nematode, Caenorhabditis elegans.   Upon exposure 
to harsh environmental conditions, including nutrient limitation, C. elegans enters a dormant 
dauer state to become stress-resistant.  C. elegans larvae lacking AMPK activity rapidly 
consume their energetic stores and die prematurely and are unable to utilize energy 
efficiently (Narbonne and Roy, 2009; Deshmukh et al., 2008).  In addition, altered locomotor 
activity, lower triglycerides, and higher oxygen consumption rates are also caused by a loss 
of AMPK function in this genetic model organism (Narbonne and Roy, 2009; Lee et al., 
2008); this parallels our findings in Drosophila.  In mammals, a recent report of altered 
AMPK activity in the mouse also shows some similar phenotypes, specifically higher 
locomotor activity and reduced triglyceride levels (Dzamko et al., 2010).   
  While such observations are consistent with the suspected roles of AMPK as a 
regulator of cellular activities, our results with an organismal reduction of AMPK function 
are not entirely expected based on all previous studies and predictions of AMPK function.  




hypothalamus during starvation conditions, which acts to stimulate feeding during low 
energy (Claret et al., 2007).  Unexpectedly, our results with Drosophila with compromised 
AMPK function globally show a similar hyperphagic response, although the relationship to 
AMPK is opposite. Additionally, AMPK has been shown to inhibit lipolysis (Sullivan et al., 
1994), yet our results show that reduced AMPK function leads to lower triglyceride levels 
instead of higher levels.  We maintain that our results do not specifically conflict with these 
reported roles for AMPK.  We note that starvation induces a series of integrated cell-
autonomous and hormonal mechanisms to coordinate organismal changes in behavior and 
physiology, with different cellular populations responding differently (Johnson and White, 
2009).   Therefore, AMPK is not the singular sensor for low energy levels, and indeed other 
mechanisms of restoring energy (i.e., autophagy), which can be independent of AMPK 
(Williams et al., 2009), are presumably responsible for modified behavioral phenotypes in 
our whole animal reduction of AMPK function.   Likewise, we suspect that in some tissues 
that the loss of AMPK may lead to resistance to nutrient deprivations, through the critical 
loss of behaviors and/or physiologies that would exhaust energy stores rapidly.  We also note 
that the transgene-drivers employed here may not reduce AMPK levels in all cellular 
populations equally, although we note that two global drivers (Ubiq-GAL4 and hsp70-
GAL4) do give similar phenotypes. Thus, our results may provide insight into the 
identification of other factor(s) that are likewise involved in mediating metabolic 
homeostasis.   
We also note that these phenotypes likely stem from the acute loss of AMPK function 
as opposed to developmental defects caused by reduced AMPK signaling.  While AMPK is 




2007), we note that induced transgene expression solely in adults leads to reduced 
survivorship during starvation.  We suspect that the metabolic phenotypes associated with 
attenuated AMPK signaling are also the cause of the lethality associated with the loss of 
AMPK function.  These larvae are slow-growing, despite actively feeding.  Our observations 
of abnormal lipid accumulation by larval oenocytes demonstrate that the loss of AMPK also 
leads to persistent starvation conditions (Gutierrez et al., 2007) at least by some cell types.    
Our results suggest a series of future experiments targeting AMPK function in various 
central populations that may mediate feeding behaviors, such as neurons that express 
neuropeptide F or the hugin – encoding peptides, both of which have been previously shown 
to modulate larval feeding (Wu et al., 2003; Melcher and Pankratz, 2005).  Likewise, other 
potential cell-specific roles of AMPK are now open to investigation in Drosophila, including 
muscle function, liver lipolysis, and locomotor behaviors.   For example, the neuroendocrine 
cells that produce the Adipokinetic Hormons (AKH) are critical for the formation of 
starvation-induced hyperactive behaviors (Isabel et al., 2005; Lee and Park, 2005).  AMPK 
may participate in this specialized population of cells to regulate AKH signaling, as well as 
in other potential cells including insulin (Rulifson et al., 2002), which is known to participate 
in the endocrine events that shape behavioral and physiological responses to starvation. 
During preparation of this manuscript, an independent report showed similar phenotypes 
stemming from reduced AMPK function (Tohyama and Yamaguchi, 2010).  This report 
showed a similar sensitivity as we have in regards to Drosophila with reduced AMPK 
function through selective introduction of an RNAi element targeting the alpha subunit.  
Moreover, this report suggests that the selective loss of AMPK signaling in muscle tissue 




variable phenotypes; this suspicion is based on the multiple functional roles reported for the 
AMPK molecule, and we have begun assessing starvation phenotypes in selective tissues in 
Drosophila. 
In addition, if AMPK functions noted here in Drosophila and previously in C. 
elegans (Gutierrez et al., 2007; Greer et al., 2007) are conserved in humans, some thought to 
global activation of AMPK as a therapeutic should be considered.  Observations in 
Drosophila (here) and C. elegans suggest loss of AMPK activity leads to difficulty 
maintaining energy stores and inefficient utilization of them; in essence excessive use of 
energy stores and “slim” animals with limited triglycerides and higher metabolism.  If the 
opposite were true during AMPK activation (for instance with an AMPK-activating drug in 
humans) one might predict highly-efficient and sparing utilization of energy stores (fat) in 
humans.   Since Type 2 Diabetes is associated with obesity and a sedentary lifestyle, such an 
effect of AMPK activators would be very undesirable and potentially lead to increased 
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The metabolic regulator AMP-activated protein kinase (AMPK) helps maintain 
cellular homeostasis through activation or inhibition of proteins involved in energy-
producing and energy-consuming pathways.  While AMPK phosphorylation targets include 
both cytoplasmic and nuclear proteins, the precise mechanisms that regulate the localization 
of AMPK, and thus its access to these substrates, are unclear.  We identify highly conserved 
carboxy-terminal hydrophobic amino acids that function as a Leptomycin-B sensitive, 
CRM1-dependent nuclear export sequence (NES) in the AMPK catalytic subunit (AMPKα). 
When this sequence is modified AMPKα shows increased nuclear localization via a Ran-
dependent import pathway.  Cytoplasmic localization can be restored by substituting well-
defined snurportin-1 or protein kinase A inhibitor (PKIA) CRM1-binding NESs into 
AMPKα.  We further demonstrate a functional requirement in vivo for the AMPKα carboxy-
terminal NES, as transgenic Drosophila expressing AMPKα lacking this C-terminal tail fail 
to rescue lethality of AMPKα null mutant flies.  Sequestered to the nucleus, this truncated 
protein shows highly reduced phosphorylation at the key Thr172 activation residue, 
suggesting that the activation of AMPK predominantly occurs in the cytoplasm under 




terminal NES provides an additional mechanism for cells to use in the regulation of AMPK 






AMP-activated protein kinase (AMPK) consists of a trimer containing a catalytic 
serine-threonine kinase subunit (α) and two regulatory subunits (β and γ) (Davies et al., 
1994; Stapleton et al., 1994) (Gao et al., 1996).  Many cellular stressors activate AMPK 
including oxidative stress, heat shock and low energy levels (low ATP/AMP ratios).   In 
response, AMPK restores energetic balance by inhibiting anabolic processes that consume 
energy, while activating catabolic pathways to conserve energy within the cell (for review 
(Hardie, 2007)).  As an example, AMPK phosphorylates and inhibits cytoplasmic acetyl 
coenzyme A carboxylase (ACC), a rate-limiting enzyme in energy-consuming fatty acid 
synthesis (Carling et al., 1987) (Davies et al., 1989), with concomitant activation of energy-
producing fatty acid oxidation, likely due to activation of carnitine-palmitoyl transferase I 
(CPT1) by increased malonyl-CoA (Hardie et al., 1998). 
 For most kinases, distinguishing in vivo from in vitro targets remains a difficult 
endeavor, as homogenized cells and tissues frequently used for in vitro kinase assays allow 
proteins that are normally either spatially or temporally separated to come into contact with 
each other.  One means for regulating kinase access to targets in vivo is through such spatio-
temporal control of each component.  Although AMPK can be found both in the nucleus and 
the cytoplasm (Salt et al., 1998), the exact mechanisms regulating its subcellular localization 
have not been fully elucidated.  In yeast, only alkaline pH has been shown to induce 
movement of SNF1 - the AMPKα orthologue in yeast - from the cytoplasm to the nucleus 
(Hong and Carlson, 2007).   In mammalian cells, leptin (Suzuki et al., 2007) and heat shock - 
possibly through MEK signaling (Kodiha et al., 2007), can also cause translocation of 




been shown to accumulate in the nucleus in a circadian fashion (Lamia et al., 2009), and 
nuclear translocation can also be induced in vivo in muscle cells after exercise stress (McGee 
et al., 2003). 
 AMPK subcellular localization could have many important functional consequences.  
The most apparent expected effects of increasing nuclear localization would include an 
increase in phosphorylation of nuclear substrates of AMPK, such as the peroxisomes 
proliferator-activated receptor gamma coactivator-1α (PGC-1α), while cytoplasmic targets 
such as ACC would show decreased phosphorylation.   To add further complexity to AMPK 
regulation, one of the upstream AMPK activators, the LKB1 kinase, also shuttles in and out 
of the nucleus (Dorfman and Macara, 2008), but is largely activated in the cytoplasm 
(Boudeau et al., 2003a).   
Primary amino acid sequence analysis can sometimes predict structure/function 
relationships for domains of a protein.  For single subunit proteins, nuclear localization 
sequences and nuclear export sequences within the protein itself help identify mechanisms 
for its localization.  However, for multi-subunit kinases like AMPK and the 
LKB1/STRAD/MO25 complex, such regulation is more complicated. 
 Although the AMPKα amino-terminus is highly conserved, containing the serine-
threonine kinase domain, the AMPKα carboxy terminus does not contain any known 
functional motifs outside of the β/γ binding sites.  We previously noted that the final 
carboxy-terminal 20 amino acids of AMPKα are highly conserved across diverse species 
(Brenman and Temple, 2007). In this study, we utilized genetic and cell biological 




new function for the carboxy-terminal amino acids of AMPKα in vivo, which affects 

























Materials and Methods 
Generating Transgenic Flies. Truncated dAMPKαΔC was cloned into a pUAST 
vector as a BglII-EcoR1 fragment of a dAMPKα-RA transcript (www.flybase.org) by 
inserting a stop codon after Proline 561 of wild type dAMPKα  using PCR-based 
mutagenesis. The GFP::dAMPKα and mCherry::dAMPKαΔC fusion proteins were made 
using GFP or mCherry at the fused in-frame to the N-terminus of dAMPKα  in the pUAST 
vector. Transgenes were introduced into a w1118 stock via P-element mediated-transformation 
by the Duke Animal Models Core facility. 
Fly Stocks and Crosses. UAS-dAMPKα wt and UAS-dAMPKαΔC alleles expressed 
in sensory neurons using a l(2)109-80-GAL4 driver (Gao et al., 1999) and recombined with 
UAS-actin::GFP to visualize sensory neurons, as described previously (Medina et al., 2006). 
For rescue experiments, both constructs were expressed using the Ubiquitin-Gal4 driver and 
crossed into dampkα3 null mutants. Adult males were scored for rescue by non-bar eye 
phenotype due to the lack of FM7 balancer chromosome. All flies were maintained at 25ºC in 
yeast-cornmeal vials.  Heat shock experiments were performed by crossing mCherry and 
GFP constructs of wild-type dAMPKα to Ubiquitin-Gal4. Third instar larvae were subjected 
to heat shock for 1 hr at 37ºC and allowed to recover for 15 minutes at 25ºC. Live larval 
imaging was performed as described (Mirouse et al., 2007) using the 488-nm argon line for 
GFP and 543-nm Helium neon line for mCherry on a Zeiss LSM510 confocal microscope. 
UAS-GFP::APC2 flies were a gift from Dave Roberts and Mark Peifer (UNC-Chapel Hill). 
Plasmid Construction. For cell culture studies, both wild-type and truncated 
versions of AMPKα2 were amplified by PCR using Pfu DNA Polymerase (Stratagene) from 




Laboratories, Inc).  Mouse AMPKα1 wild-type and truncated versions were generated using 
PCR amplification from mouse cDNA and inserted into pEGFP-C1.  The SV40-NLS 
(PKKKRKVG), AMPKα2  and AMPKα1 C-terminal tail tags were cloned into the C-
terminus of the pEGFP-C1:: GFP construct. For expressing the SV40NLS and the 
AMPKα2 C-terminal tag together, the SV40NLS coding sequence was inserted into the N-
terminal forward primer for amplification of the GFP coding sequence. The SV40NLS::GFP 
amplicon was then inserted into a pEGFP-C2 plasmid containing the AMPKα2 C-terminal 
tail coding sequence at the C-terminus of that plasmid.  
 L546A and L550A substitutions in the AMPKα2 C-terminal tail sequence was 
inserted into the reverse primer sequence and cloned using site directed mutagenesis. HA-
tagged human AMPKγ1 and rat AMPKβ1 constructs were gifts from Reuben Shaw (UCSD), 
mCherry::AMPKγ1 was produced by inserting human AMPKγ1 into a modified pEGFP-N1 
vector with GFP replaced by Flag::mCherry (gift from Tom Maynard, UNC-Chapel Hill). 
Myc-tagged clones of wild-type AMPKα2, AMPKα2ΔC, and AMPKα2L,L-A,A constructs 
were all generated using standard site directed mutagenesis and inserted into the pCMV-myc 
vector (Clontech, 631604). The RanQ69L clone was a gift from Andrew Wilde (University 
of Toronto), which was then inserted into a pmCherry-C1 plasmid for live cell visualization. 
 To generate AMPK-CRM1-NES fusions, sequences encoding residues Met1 to Val14 
(human Snurportin-1) or Ser35 to Ile47 (human cAMP-dependent protein kinase inhibitor 
alpha (PKIA)) were added after Asp538 of rat AMPKα2, replacing the C-terminal tail.  
Truncated AMPKα2 missing only the last 14 amino acids (AMPKα2ΔC538) was produced by 
introducing a UGA stop codon after Asp538.  For GFP-tagged constructs, products were 




myc-tagged constructs, the coding regions were amplified from the above GFP-AMPKα2 
plasmids and inserted into the pCMV-myc vector. 
Immunohistochemistry. AMPKα localization in fly tissue was determined using 
standard dissection and immunostaining procedures (Medina et al., 2006). The primary 
antibody was anti-AMPKα (mouse) (Abcam: ab51025) and the secondary antibody was Cy-3 
conjugated anti-mouse (1:200, Jackson ImmunoResearch Laboratories, Inc.). During the 
wash steps, ToPro-3 (Invitrogen) was added to the wash solution and incubated for 30 
minutes to stain nuclei. Larval fillets were mounted on slides in 70% glycerol in 1xPBS. 
Images were collected by confocal microscopy with a 40x oil immersion lens (LSM 510; 
Carl Zeiss Microimaging Inc.) using suitable GFP, Cy3 and ToPro-3 excitation wavelengths.  
AMPKα  Immunoprecipitation. Drosophila protein lysates for immunoprecipitation 
were prepared by collecting equal numbers of male and female flies (50 total) of each 
genotype in a 1.5 ml tube. One ml lysis buffer (20 mM Tris-Cl pH 7.5, 150 mM NaCl, 1 mM 
EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate 1 mM b-
glycerolphosphate, 1 mM sodium orthovanadate, 1 mM PMSF, and 1:500 dilution of Sigma 
mammalian protease inhibitor cocktail) was added to each sample.  Flies were then ground to 
homogeneity with a pestle, sonicated, and centrifuged at 16,000xg for 10 minutes at 4°C to 
remove insoluble material and debris.   Supernatants were collected, and the protein 
concentration was determined using the Bio-Rad Dc Protein Assay.   Immune complexes 
were formed by incubation of 100 µl of anti-dAMPKα mouse monoclonal antibody (Abcam 
ab51025) with 1 mL of 1 mg/mL fly lysate overnight at 4°C.  Antibodies were precipitated 
by incubation with 20µl protein A/G agarose (Pierce Protein Research Products) for 3 hours, 




70°C incubation in LDS-loading buffer (Invitrogen Corporation) and separated on 4-12% 
Bis-Tris NuPAGE gels along with 50 µg of crude lysates.  Electrophoresis was followed by 
Western blotting and probing for phospho-AMPKα (Cell Signaling Technology, #2535) and 
total dAMPKα, with anti-Lamin C (LC28.26, Developmental Studies Hybridoma Bank) used 
as a loading control. 
AMPKα/β/γ  Co-Immunoprecipitation. HEK293 cells were transiently transfected 
with myc-tagged AMPKα2, HA-tagged AMPKβ1, and FLAG-tagged Cherry-AMPKγ1 in 10 
cm dishes.  Cells were harvested and lysed in 0.5 ml lysis buffer (see above), sonicated, and 
centrifuged at 16,000xg for 10 minutes at 4°C.  Protein concentrations of supernatants were 
determined followed by overnight incubation of 1 ml of 1 mg/ml of each lysate with 100 µL 
of anti-myc antibody (9E 10, Developmental Studies Hybridoma Bank). Antibody 
precipitation and blotting were performed as described above. Primary antibody dilutions 
were anti-Myc (1:100), anti-HA (1:250, Santa Cruz, F-7), and anti-FLAG (1:1000, Sigma, 
M2).  All blots were scanned and quantified using the Odyssey Infrared System (LI-COR 
Biosciences) using fluorescently-labeled secondary antibodies (LI-COR, IRDye 680 anti-
rabbit IgG and IRDye 800 anti-mouse IgG). 
Cell Culture and Treatments. HEK293, HeLa and CHO cells were cultured in 
DMEM medium supplemented with 10% Fetal Bovine Serum and penicillin-streptomycin. 
Cells were plated 24 hr prior to transfection.  DNA transfection of cells (1 µg of DNA to 2ml 
of medium) was performed using PolyJet DNA Transfection Reagent (SignaGen 
Laboratories), as directed by the supplier.  Leptomycin B (10 ng/ml, Sigma) and 




Cells were treated with cycloheximide for 1 hr before addition of Leptomycin B mix for 
indicated times. 
Nuclear Localization Assay, Live Cell Imaging and Tiling. HEK293 cells were 
transfected with the constructs indicated and scored 24 hours later using fluorescence 
microscopy to observe the sub-cellular localization of GFP. 2xGFP alone was the negative 
control for localization and for treatment with Leptomycin B. For each GFP fusion, 200 cells 
were counted and scored as: predominantly nuclear, nuclear and cytoplasmic, or 
predominantly cytoplasmic localization. For imaging, cells were fixed and stained with 
DRAQ-5 (Biostatus Limited) to visualize nuclei. For live cell imaging, 24 hours post-
transfection the cells were treated with cycloheximide (1µg/ml) for 1 hour followed by 
treatment with Leptomycin B (10ng/ml). Pictures were taken every 10 minutes for GFP 
localization using an Olympus FV100 microscope. Tiling images were also taken using the 
Olympus FV100 Multi-Area Time Lapse Imaging program followed by counting and 
deciphering of the subcellular localization of GFP as previously described (Henderson, 
2000). To control for biased counting, 50 cells from each of the three classes (N, NC, and C) 
were selected and the fluorescence intensities were quantified as previously described 
(Henderson, 2000). For cells identified as predominantly nuclear, the ratio of nuclear to 
cytoplasmic GFP level in a cell was greater than 2, for nuclear and cytoplasmic localization 
the same ratio was between 0.7 and 2, and for predominantly cytoplasmic localization the 








The AMPKα  Carboxy-Terminus is Required for Function. Despite containing a 
highly conserved carboxy terminus ((Brenman and Temple, 2007) and (Figure, 4-1A and B)), 
the AMPKα C-terminal 23 amino acids do not contain predicted functional motifs.  Co-
crystal structures of the carboxy terminus of AMPKα with β/γ subunits indicate that the 
carboxy-tail participates in intermolecular interactions with the β subunit and intramolecular 
interactions with the rest of the C-terminal domain (Amodeo et al., 2007; Xiao et al., 2007), 
although previous studies also suggest that the AMPKα carboxy-tail is not required for 
association with the β/γ subunits (Iseli et al., 2005).   
To test the functional significance of the AMPKα carboxy terminus, we generated 
transgenic Drosophila expressing full-length AMPKα lacking the final 22 amino acids 
(AMPKαΔC) for reintroduction into AMPKα mutant or wild type backgrounds.  While 
vertebrates contain two largely genetically redundant AMPKα genes, Drosophila encodes 
only a single AMPKα gene thus greatly simplifying in vivo genetic analyses. Expression of 
full-length (amino terminally-tagged or untagged) versions of AMPKα in a null background 
rescues the previously identified neuronal phenotype ((Mirouse et al., 2007) and Figure 4-
1C), while AMPKαΔC versions do not (Figure 4-1C).  Further, although both N-terminally 
GFP-tagged or mCherry-tagged AMPKα rescue lethal null mutations to full viability at 
expected Mendelian ratios (data not shown), neither untagged nor tagged AMPKαΔC rescue 
any mutant alleles to viability (scoring over one thousand potential rescue events).  These 
experiments indicate a crucial function for the carboxy-terminal 22 amino acids of 











Figure 4-1. AMPKα  contains a highly conserved carboxy-terminal tail required for 
function in vivo. (A) Schematic of AMPKα homology with blocks highlighting regions with 
>50% conservation among bilateria (rat AMPKα2  as template; calculated by ProPhylER). 
Amino acid numbers denote the ranges. (AID: autoinihibitory domain; 398-472: previously 
mapped site for β and γ subunit binding)  (B) The carboxy-terminal tail sequence alignment 
of AMPKα orthologues with conserved residues highlighted in blue and invariant residues in 
red (AMPKα2 for species with multiple AMPKα subunits). (C) Peripheral neurons 
visualized by Gal4 109(2)80-driven expression of UAS-actin::GFP in wild type (WT) 
Drosophila 2nd instar larvae, AMPKα loss of function (AMPKα3) larvae,  AMPKα3 
expressing a wild type AMPKα transgene (80>UAS-AMPKα), or AMPKα3 expressing a C-
terminally truncated AMPKα transgene (80>UAS-AMPKα ΔC).  Dendritic swellings are 















The Carboxy-Terminal 22 Amino Acids of AMPKα  are Required for Normal 
Localization in vivo.  In order to explore why a 22 amino acid carboxy terminal deletion of 
AMPKα fails to rescue AMPKα null mutants, we examined the localization of the truncated 
protein both by antibody immunohistochemistry and visualization of fluorescently tagged 
fusion protein.  Expression of untagged AMPKα in transgenic animals and subsequent 
detection of AMPKα by immunohistochemistry revealed very clear subcellular localization 
differences between full-length and truncated protein (AMPKαΔC) (Figure 4-2A).  
AMPKαΔC localizes predominantly in the nucleus whereas full-length protein is both 
cytoplasmic and nuclear, using either immunohistochemistry of untagged protein (Figure 4-
2A) or live animal images with fluorescently tagged proteins (Figure 4-2B).  The observation 
that AMPKαΔC is highly enriched in the nucleus was observed in diverse tissues including 
neurons, muscle, fat bodies and salivary glands (Figure 4-2 and data not shown).  Differential 
subcellular localization of AMPKα with and without the carboxy terminus is most clearly 
demonstrated using a live transgenic animal simultaneously expressing both full length and 
AMPKαΔC in the same cells (Figure 4-2B).  This observation was not restricted to 
Drosophila in vivo, as a conceptually similar result was observed in transiently transfected 
mammalian cells (HEK293) in vitro (Figure 4-2C).  Counting of transfected mammalian cells 
for subcellular localization demonstrated a clear difference between full-length AMPKα and 





















Figure 4-2.  AMPKα  lacking the carboxy terminus localizes predominantly to nuclei in 
vivo and in vitro. (A) Indirect immunofluorescence of AMPKα (red) staining with anti-
dAMPKα antibody on transgenic Drosophila third-instar larvae expressing either full-length 
wild type AMPKα or the carboxy-truncated AMPKα (AMPKαΔC).  All transgenic proteins 
are expressed using the Gal4-UAS system, driven by Ubiquitin-Gal4 (A and B).  Nuclei were 
stained with ToPro-3 (blue).  (B) Live animal images of larvae expressing amino-terminal 
mCherry-tagged wild type (mCherry-AMPKα) or truncated (mCherry-AMPKαΔC) 
AMPKα, GFP-tagged wild type α (GFP-AMPKα) alone or in combination with mCherry-
tagged truncated α (mCherry-AMPKαΔC+GFP-AMPKα). Bar, 10µm.  (C) Co-expression of 
amino-terminal fluorescently-tagged full-length AMPKα2 (mCherry-AMPKα, red) and 
truncated (GFP-AMPKαΔC, green) in the same co-transfected mammalian cells (HEK293). 
(D) Scoring of transfected cells for subcellular localization of GFP-tagged full-length (GFP-
AMPKα) or truncated (GFP-AMPKαΔC) AMPKα as primarily nuclear (N), both nuclear 
and cytoplasmic (NC) or primarily cytoplasmic (C).  Proper scoring for each group was 
confirmed by quantification of nuclear and cytoplasmic fluorescence for >50 cells in each 











 The AMPKα  Carboxy-Tail Functions as a Leptomycin B-Sensitive Nuclear 
Export Sequence (NES). To elucidate whether the carboxy-terminus might act as a nuclear 
export sequence in AMPKα localization, we used a previously described mammalian cell 
assay to test for sequences that alter the subcellular localization of proteins (Frederick et al., 
2008).  We fused the AMPKα carboxy-tail in frame at the C-terminus of two tandem GFP 
molecules (Figure 4-3A).  Two consecutive fused GFPs (2xGFP, ~54kD) localize diffusely 
within the nucleus and the cytoplasm (as previously reported (Frederick et al., 2008) and 
Figure 4-3B).  Adding the 23 amino acid carboxy tail of rat AMPKα2 (2xGFP-α2 tail) leads 
to localization predominantly in the cytoplasm (Figure 4-3B).   
 As a previous study demonstrated that endogenous (untagged) AMPKα protein in HeLa 
cells enriches in the nucleus upon treatment with Leptomycin B (LMB) (Kodiha et al., 2007), 
a specific inhibitor of CRM1-mediated nuclear export (Kutay and Guttinger, 2005), we tested 
whether LMB specifically inhibits this AMPKα tail-dependent nuclear export.  Indeed, LMB 
treatment does result in altered localization of the 2xGFP-α2 tail from predominantly 
cytoplasmic (Figure 4-3B) to both nucleus and cytoplasm (Figure 4-3D).  This effect of LMB 
can also be illustrated using time-lapse experiments, showing accumulation of proteins 
containing the carboxy tail of AMPKα2 in the nucleus within 10 minutes of LMB addition 
(Figure 4-4).   
 Since CRM1 NESs are often leucine-rich (Kutay and Guttinger, 2005), we specifically 
mutated two conserved leucines in the carboxy tail (2xGFP-α2L,L→A,A) (Figure 4-3D), which 
altered localization to both nuclei and cytoplasm similar to treatment of 2xGFP-α2 tail with 
LMB.  Identical results were obtained using the carboxy tail of AMPKα1 (data not shown), 




the same positions and suggests that any difference between AMPKα1 and AMPKα2 
localization is not due to their tail sequences.  Using a larger GFP-tagged construct 
containing full length AMPKα with the dual leucine mutations (GFP-AMPKαL,L→A,A) 
resulted in even more pronounced accumulation in the nucleus (Figure 4-3, E and F), perhaps 
due to diminished non-directional diffusion through the nuclear pore or the presence of 
nuclear import signals elsewhere on AMPK. 
 Addition of the carboxy terminal tail of AMPKα2 to 2xGFP was even sufficient to 
overcome nuclear targeting via the SV40 NLS (SV40-NLS α2 tail, Figure 4-3B).  This effect 
was not due to inactivation of the SV40 NLS, as treatment with LMB induced accumulation 
of the NLS-containing protein in the nucleus (Figure 4-4). As the tail appears to act as a 
CRM1-dependent NES, we compared the AMPKα tail sequence to known CRM1-dependent 
nuclear export sequences (NESs) (Figure 4-3C).  Although the precise positioning of key 
residues for CRM1-dependent NESs vary, they are generally highly enriched for bulky 
hydrophobic amino acids (φ = leucine, isoleucine, phenylalanine, valine, methionine) at 
specified spacings (φ-x-2/3-φ-x-2/3-φ-x-φ) (Kutay and Guttinger, 2005), generally consistent 
with an α helix.  AMPKα carboxy tails are also enriched for bulky hydrophobic amino acids 
(Figure 4-1B), only one residue away from being a canonical NES (Figure 4-3C). (Yeast 
SNF1 does indeed match the consensus NES.) However, other proteins with defined NESs, 
including the nuclear-cytoplasmic shuttling heat stress protein, HsfA2, also vary from the 
canonical consensus containing either four or five bulky hydrophobic residues at more 
flexible spacings (Heerklotz et al., 2001). According to these more flexible criteria, AMPKα 




 AMPKα carboxy termini contain other conserved residues - including a conserved 
cysteine and threonine (Figure 4-1B), suggesting that these residues may be modified in vivo 
to alter either AMPK activity or localization. In Drosophila, mutating the carboxy tail 
Cys573 to serine rescued both the neuronal phenotype and lethality of AMPKα null mutants 
(data not shown), indicating that this cysteine is not essential.  Further, in mammalian cells, 
mutating Thr536 to either a phosphomimetic (aspartate) residue or to an alanine failed to 
affect the localization of the 2xGFP-α2 tail protein compared to the wild type tail (data not 
shown).  Therefore we focused our further investigation on the conserved bulky hydrophobic 


























Figure 4-3. The carboxy-terminal tail of AMPKα  functions as a nuclear export 
sequence (NES). (A) Schematic representation of the four constructs containing two tandem 
GFP molecules (2xGFP) with or without the carboxy-terminal 23 amino acids of AMPKα2 
(red) and/or the SV40 NLS (blue) used in (B).  (B) HEK293 cells transfected with constructs 
containing 2xGFP alone, 2xGFP with the SV40-NLS, 2xGFP with the AMPKα2 tail, or 
2xGFP with both the SV40 NLS and the α2 tail. Nuclei are stained with DRAQ5 (blue).  (C) 
Alignment of the AMPKα2 tail with confirmed CRM1-dependent nuclear export sequences.  
The CRM1-NES consensus sequence is shown, consisting of either four or five bulky 
hydrophobic amino acids (φ, red) with variable spacing between them.  Key leucine residues 
(often enriched in CRM1 NES sequences), L546 and L550, that were mutated for (D) are 
highlighted with asterisks (*).  (D) Cells expressing either 2xGFP fused to the wild type α2 
tail and treated with the CRM1-specific inhibitor Leptomycin B (LMB), or 2xGFP with 
L546A and L550A (L,L→A,A) mutations in the α2 tail, to block CRM1-mediated nuclear 
export (compare to α2 tail in (B). (E) Cells transfected with a GFP-tagged full-length 
AMPKα2L,L→A,A mutant. (F) Scoring of cells for subcellular localization of GFP-AMPKα 
with the L,L→A,A mutations to nucleus (N), nucleus and cytoplasm (NC) or cytoplasm 













Figure 4-4.  Leptomycin B (LMB) treatment, a specific inhibitor of CRM1-mediated 
nuclear export, induces accumulation of AMPKα  carboxy tail-containing proteins in 
the nucleus in a time-dependent manner.  HEK 293 cells transiently transfected with either 
2xGFP or 2xGFP fusions containing the AMPKα2 C-terminal tail, the SV40 NLS, or both 






AMPKα  Cytoplasmic Localization can be Restored Using Other Defined 
Nuclear Export Sequences. Having identified sequences required for NES function at the 
carboxy-terminus of AMPKα, we wondered whether other well-documented NESs would 
function in lieu of the AMPKα carboxy-tail sequence.  First, we further refined the putative 
AMPKα NES to within the carboxy-terminal 14 amino acids based on sequence alignment 
with other previously characterized CRM1-dependent NESs (Figure 4-3C) and confirmed the 
functional consequences of truncating only the final 14 amino acids (AMPKαΔC538), as this 
shorter truncation also localizes to the nucleus (Figure 4-5A).  We then chose two well-
characterized NESs to replace the putative AMPKα NES; there is a crystal structure of 
snurportin-1 (SNUPN) bound to CRM1 (Dong et al., 2009), while protein kinase A inhibitor 
(PKIA) contains a distinct but also well-characterized NES (Fornerod et al., 1997).  Both 
NESs served to restore the AMPKαΔC538 fusion protein to the cytoplasm (Figure 4-5A), The 
transplanted NESs did not act by disrupting nuclear import, as both constructs showed 
increased nuclear localization in the presence of LMB (data not shown).  Additionally, the 
SNUPN-NES and PKIA-NES AMPKα chimeric constructs retain significant affinity for β 
and γ by co-immunoprecipitation (Figure 4-5B), despite having no sequence identity with the 
AMPKα tail, indicating that these localization changes are not due to disruption of the 
AMPK heterotrimer. As further confirmation that AMPK α/β/γ binding is not responsible for 
these α-tail-mediated changes in localization, we found that the construct which most 
strongly abolishes AMPKα cytoplasmic localization (AMPKαL,L→A,A), and contains the 
fewest amino acid changes, retains essentially wild-type binding to the β and γ subunits 










Figure 4-5. Previously identified Nuclear Export Sequences (NESs) can substitute for 
the carboxy-terminus of AMPKα  to restore cytoplasmic localization. (A) HEK 293 cells 
transiently transfected with GFP-tagged AMPKα2 constructs containing the L546A and 
L550A mutations (AMPKαL,L→A,A), a 14 amino acid C-terminal deletion (AMPKαΔC538), or 
with the 14 C-terminal residues of AMPKα2 replaced with the CRM1-dependent nuclear 
export sequences from human snurportin-1 (SNUPN, MEELSQALASSFSV, 14 amino acids) 
or cyclic-AMP-dependent protein kinase inhibitor α (PKIA, SNELALKLAGLDI, 13 amino 
acids). Bar, 10 µm.  (B) AMPKα, β, and γ subunits were co-immunoprecipitated with anti-
myc antibody from HEK cell lysates either expressing HA-tagged AMPKβ1 and FLAG-
tagged AMPKγ1 alone (first lane), or coexpressed with myc-tagged wild type AMPKα, 
L546A/L550A (L,L→A,A) AMPKα, or SNUPN and PKIA AMPKα-NES chimeras.  (C) 
The relative association of β and γ subunits with myc-tagged wild type, L,L→A,A mutant, or 
NES chimera AMPKα variants normalized to AMPKα wild type levels, calculated from the 













The Carboxy-Terminal AMPKα  Tail is not Required for Binding β/γ  Subunits. 
Although the carboxy tail of AMPKα appears to act as a nuclear export sequence, previous 
immunoprecipitation experiments with transfected cells mapped the β binding site to amino 
acids 313-473 of AMPKα (Iseli et al., 2005), indicating that the carboxy tail of AMPKα is 
not required for association with the β/γ subunits. The AMPK heterotrimer crystal structures 
also indicate that the γ subunit has minimal contact with the carboxy tail of AMPKα/SNF1 
(Amodeo et al., 2007; Xiao et al., 2007).    Using co-immunoprecipitation experiments, we 
also confirmed that the carboxy tail is not required for AMPKα/β/γ association in transfected 
cells, as β and γ both still associate with AMPKαΔC (Figure 4-6). However, the tail may 






















Figure 4-6.  Truncated AMPKα lacking the carboxy-terminal 23 amino acids (AMPKαΔC) 
associates with β/γ subunits in transfected cells by anti-myc immunoprecipitation. Western 
blot of anti-myc immunoprecipitations from lysates of HEK 293 cells co-transfected with 
HA-tagged AMPKβ, FLAG-tagged AMPKγ (all three lanes), and either myc-tagged full-
length AMPKα2 (lane 1) or C-terminally truncated AMPKαΔC (lane 3).  Cells with no myc-







AMPKα  Nuclear Entry is Dependent on Ran. As the AMPK trimer complex is too 
large to passively diffuse into the nucleus, we sought to clarify the mechanism of its active 
transport. While many proteins are imported into the nucleus through Ran-dependent binding 
to members of the Importin (Imp) family (Strom and Weis, 2001) (for review (Weis, 2003)), 
proteins may also be translocated through Ran-independent pathways, such as through direct 
binding to the nuclear pore complex (Matsubayashi et al., 2001). 
 Several signaling proteins, including ERK2 and MEK1, have a conserved sequence 
motif (TPT or SPS), in which phosphorylation of these residues will induce translocation into 
the nucleus in a Ran-independent manner (Chuderland et al., 2008).  While the AMPKα 
isoforms contain similar sequences (TPS in α1 and TPT in α2), mutation of these residues to 
alanine or phosphomimetic glutamic acid residues failed to affect the localization of the 
truncated form of AMPKα (data not shown). 
 To further distinguish between the possible import pathways responsible for AMPK 
translocation, we examined the effect of a Ran mutant (RanQ69L) that halts Ran-dependent 
nuclear import and export by blocking its GTP hydrolysis (Bischoff et al., 1994).  
Transiently transfecting cells with this Ran mutant along with GFP-tagged AMPKα, we see 
that AMPKα is restricted to the cytoplasm (2nd row, Figure 4-7), as is its upstream activator 
LKB1 ((Dorfman and Macara, 2008) and 4th row, Figure 4-7).  Even the carboxy-terminal 
AMPKα truncation (AMPKαΔC), that is normally strongly nuclear, localizes similarly to 
full-length AMPKα in the presence of RanQ69L (3rd row, Figure 4-7), indicating that 
AMPKα is normally basally imported via a Ran-GDP-dependent pathway. 
 Conventional nuclear localization signals (NLSs) are typically enriched for a single 




linker region of 10 to 12 residues (Leung et al., 2003).  AMPKα2 but not AMPKα1 has been 
proposed to contain a K-K/R-x-K/R NLS within the kinase domain that is activated by leptin 
in C2C12 cells (Suzuki et al., 2007), allowing differential localization between AMPKα1 
and AMPKα2.   Although it is not known whether HEK cells respond to leptin, we did not 
observe any difference in localization between AMPKα1 and AMPKα2 with or without 
mutations in this putative kinase domain NLS (data not shown), indicating that this leptin-
stimulated nuclear translocation does not function in HEK cells.   Along with our findings 
using RanQ69L and the nuclear localization of the truncated AMPKα in several cell types in 
Drosophila, these results ultimately suggest that AMPK contains another Ran-dependent 
NLS, either elsewhere in α, or in the β or γ subunits that is basally active. 
 We also found that the phosphorylation state of the truncated AMPKα does not affect its 
nuclear translocation, as HEK cells transfected with C-terminally truncated AMPKα 
constructs containing T172D and T172A mutations in the activation loop localized similarly 















Figure 4-7.  AMPKα , like LKB1, requires Ran-GTP hydrolysis for nuclear import. 
HEK 293 cells transiently transfected with constructs expressing 2 fused GFP molecules 
(2xGFP), GFP-tagged full-length AMPKα2, truncated AMPKα2 (AMPKαΔC) or LKB1, 
with or without the GTP-hydrolysis defective Ran mutant RanQ69L.  Nuclei are stained with 





 Heat Shock Increases Nuclear AMPKα  in vivo. Numerous in vitro studies have 
suggested changing cellular environments/conditions may change AMPKα localization, 
including alkaline pH, heat shock and oxidative stress, and leptin stimulation (Hong and 
Carlson, 2007; Kodiha et al., 2007; Suzuki et al., 2007). We wondered whether these 
stressors that affect AMPKα localization in vitro, might also affect AMPKα localization in 
vivo.   Indeed, using live transgenic animal (larvae) imaging, we found that heat shock 
induced nuclear enrichment of AMPKα in vivo (Figure 4-8).  While both GFP- and mCherry-
tagged AMPKα increased nuclear enrichment upon heat shock (Figure 4-8, D and E), other 
GFP-tagged proteins, including APC2, which contains both NES (Rosin-Arbesfeld et al., 
2000) and NLS (Zhang et al., 2000) sequences, did not localize to the nucleus under heat 
shock (Figure 4-8F).  Other stressors, including inducing oxidative stress by feeding larvae 


















Figure 4-8. Heat shocked transgenic larvae demonstrate increased nuclear localization 
of AMPKα  in vivo. Live animal images of 3rd instar Drosophila larvae expressing GFP-
tagged (A, D) or mCherry-tagged wild type AMPKα (B, E), mCherry-tagged truncated 
AMPKαΔC (C), or GFP-tagged APC2 (containing both NLS and NES sequences).  Animals 
in D-F were subjected to heat shock at 37°C for 1 hour, followed by a 15 minute recovery at 
25°C.  All transgenic proteins are expressed using the Gal4-UAS system, driven by 








The Truncated Nuclear AMPKα  Isoform Shows Reduced Phosphorylation in 
vivo. Although there are clear differences in AMPKα localization dependent on the carboxy-
terminal putative NES, we wondered what downstream consequences might be elicited.  For 
example, LKB1, an upstream activator of AMPKα, requires cytoplasmic localization for 
activation (Baas et al., 2003; Boudeau et al., 2003a).  To determine whether or not the 
differentially localized AMPKα, with or without the putative NES, might also affect the 
phosphorylation of the invariant Thr172 (Thr184 in Drosophila) that is required for AMPK 
activity (Lizcano et al., 2004), we measured the phosphorylation levels of Thr184 in 
transgenic Drosophila animals expressing either wild type or truncated AMPKαΔC by 
western blot. Quantification of phospho-AMPKα in either total lysates or 
immunoprecipitated AMPKα, normalized to total AMPKα levels, indicates that only ~20% 
of the truncated nuclear-enriched protein (Figure 4-2) is phosphorylated relative to wild type 




















Figure 4-9. Phosphorylation of the activation loop threonine (T184) in Drosophila 
AMPKα  is reduced in a nuclear enriched form in vivo. (A) Western blot of total lysates 
from transgenic Drosophila flies expressing Gal4 alone, mCherry-tagged full length 
AMPKα, or mCherry-tagged truncated AMPKα (AMPKαΔC) probed for phospho-AMPKα, 
total AMPKα, and Lamin C (loading control).  (B) Western blot of proteins 
immunoprecipitated with anti-AMPKα antibody from fly lysates from the above fly lines, 
probed for phospho- and total AMPKα.  Both AMPKα protein constructs are overexpressed 








For enzymes in particular, subcellular protein localization plays a key role in the 
proper functioning of cells by enabling interaction with required substrates and preventing 
unwanted side-reactions. Regulation of subcellular localization, studied for numerous 
nucleocytoplasmic-shuttling signal transducing proteins (Xu and Massague, 2004), adds an 
additional layer of complexity, enabling changes in access to substrates as well as upstream 
activators and inhibitors depending on the needs of the cell.   
As an example, the upstream AMPK activator LKB1, under different stimuli, can 
localize to either the nucleus or cytoplasm, greatly affecting its own activity.  Some LKB1 
mutations that cause human Peutz-Jeghers syndrome constitutively sequester LKB1 to the 
nucleus, and despite being outside the kinase domain, are phenotypically indistinguishable 
from mutations that abolish enzymatic activity, (Nezu et al., 1999; Boudeau et al., 2003b; 
Xie et al., 2009). Although the mechanism of LKB1 localization is complex, it involves other 
proteins, including the STRADs (STE related adapter) that form a complex with LKB1, 
promoting nuclear export and inhibiting nuclear import (Boudeau et al., 2003a; Dorfman and 
Macara, 2008).  Although LKB1 is an upstream activator of AMPKα (Lizcano et al., 2004) 
and both proteins are kinases, LKB1 can function without other subunits bound, while 
AMPK is generally thought of as an obligate trimer (Hardie, 2007).   
 Previous studies have elucidated both nuclear and cytoplasmic targets of AMPK.  In 
the cytoplasm, AMPK most notably phosphorylates and inhibits acetyl Co-A carboxylase 
(ACC), a rate-limiting enzyme required for fatty acid synthesis (Carling et al., 1989).  
Conversely, there are several known nuclear targets of AMPK (Leff, 2003; Bronner et al., 




transcription in the nucleus.  Furthermore, AMPK accumulation in or dispersion from the 
nucleus can be regulated by exercise, cellular stress and circadian rhythms.  In one study, 
exercise increased induced nuclear translocation of AMPKα2 in skeletal muscle, (McGee et 
al., 2003), where AMPK is known to activate PGC1α and subsequent gene transcription 
(Jager et al., 2007).  Another more recent study has demonstrated that AMPKα1 in the 
nucleus fluctuates in a circadian manner, regulating the circadian clock by inducing 
degradation of cryptochrome 1 (Lamia et al., 2009).  Clearly, mechanisms that regulate 
AMPK subcellular localization are widely utilized to modulate its access to downstream 
substrates. 
 The nuclear pore complex (NPC) plays a key role as a molecular sieve to help 
compartmentalize proteins between nucleus and cytoplasm.  Indeed, many 
nucleocytoplasmic shuttling proteins contain signals to direct them in and/or out through the 
NPC (Yasuhara et al., 2009).  An AMPK trimer would far exceed the generally accepted 
nuclear pore diffusional cut-off size of 40 kDa (Gorlich and Kutay, 1999), and would thus 
also need such NPC shuttling signals.  Despite distinct AMPK targets in both the nucleus and 
cytoplasm, the mechanisms for regulating its localization remain unclear, particularly in 
organisms that have only single α/β/γ subunits (e.g. Drosophila), where localization models 
based on different genetically-encoded isoforms are not applicable.  
One previous model for nuclear AMPK localization proposes that AMPKα2, but not 
AMPKα1, contains an NLS in the kinase domain that becomes functional only upon addition 
of leptin (Suzuki et al., 2007).  As not all organisms encode leptin, and we did not observe 
any localization differences for AMPKα2 when mutating key residues in the proposed leptin-




localization is likely cell type-dependent. This can also be seen in the differential localization 
between AMPKα1 and AMPKα2 isoforms in insulinoma cells (Salt et al., 1998), in contrast 
to HEK cells, where α1 and α2 localize similarly (data not shown).  These effects are also 
seen with the β subunit, as only AMPKβ1 enriches in the nucleus upon mutation of two 
phosphorylation sites in HEK cells (Warden et al., 2001), while AMPK complexes 
containing β2 preferentially localize in the nucleus in C2C12 cells under leptin treatment 
(Suzuki et al., 2007).  Distinct SNF1 β subunits are also thought to promote differential 
subcellular localization in yeast (Vincent et al., 2001).  Altogether, these results suggest that 
cells differentially regulate AMPK localization, and thus activity, through multiple pathways, 
depending on their unique metabolic requirements and hormonal responses.   
The findings herein identify amino acids at the carboxy terminus of AMPKα that modulate 
its nuclear export (Figures 1 and 3) that are nearly universal, with these sequences found 
across phyla (Figures 1 and 3), closely matching the consensus sequence for the leucine-rich 
CRM1-dependent nuclear export sequences (la Cour et al., 2004).   As C-terminally truncated 
AMPKα localizes to the nucleus in vitro in HEK cells, and in vivo in Drosophila under 
unstressed conditions, this suggests that AMPKα is basally imported to the nucleus, and that 
regulation of AMPK localization in response to stress would predominantly be affected 
through modulation of the export pathway.   Adding further complexity, localization of the 
AMPK complex and partitioning of specific subunits may also be both cell type and context-
dependent.  For instance, in multicellular organisms certain tissues (e.g. fat) provide energy 
to other tissues/organs (e.g. muscle) at their own expense.  In these cases, AMPK activation 
likely leads to different physiological outcomes between cell types, such as increased lipid 




differential localization of AMPK in distinct cell types could be used to generate these 
different cellular responses.  
 A further avenue of inquiry in regulation of AMPK localization is in the possible 
effects of post-translational modification of AMPK subunits on the accessibility of the 
carboxy-tail of AMPKα.  As the AMPKα carboxy-tail folds into a pocket formed by the α 
and β subunits after a long flexible loop (Amodeo et al., 2007; Xiao et al., 2007), altering the 
strength of these interactions could change its accessibility to CRM1, thus activating or 
inhibiting nuclear export.  Although there are conserved residues that could be post-
translationally modified in the AMPKα carboxy-tail adjacent to the putative NES, we have 
so far been unable to identify residues flanking the NES that change the subcellular 
localization of AMPKα in vitro or are required for genetic rescue in vivo, as described 
earlier.  One tantalizing possibility is that the potential phosphoserine mutations in β1 
increase nuclear localization of AMPK by enhancing β interactions with the AMPKα tail, 
thus blocking nuclear export. 
 Whatever mechanisms determine AMPK localization, they must take into account 
two general observations: 1) AMPKα1 and AMPKα2 are largely genetically and 
functionally redundant in the mouse and 2) many organisms encode only a single isoform for 
individual AMPK subunits.   In many mouse strains AMPKα1 and AMPKα2 are genetically 
redundant as single α1 knockouts or α2 knockouts are viable, yet double knockouts are lethal 
(personal communication B. Viollet), suggesting that different AMPKα isoforms are 
functionally redundant for activities required for life in vivo.  Therefore the elucidation of 




as the ones identified in this study, is vitally important to the understanding AMPK 
















































Amodeo, G.A., Rudolph, M.J., and Tong, L. (2007). Crystal structure of the heterotrimer  
cerevisiae AMPK homologue SNF1. Nature 449, 492-495. 
 
Baas, A.F., Boudeau, J., Sapkota, G.P., Smit, L., Medema, R., Morrice, N.A., Alessi, D.R., 
and Clevers, H.C. (2003). Activation of the tumour suppressor kinase LKB1 by the 
STE20-like pseudokinase STRAD. Embo J 22, 3062-3072. 
 
Bischoff, F.R., Klebe, C., Kretschmer, J., Wittinghofer, A., and Ponstingl, H. (1994). 
RanGAP1 induces GTPase activity of nuclear Ras-related Ran. Proc Natl Acad Sci U 
S A 91, 2587-2591. 
 
Boudeau, J., Baas, A.F., Deak, M., Morrice, N.A., Kieloch, A., Schutkowski, M., Prescott, 
A.R., Clevers, H.C., and Alessi, D.R. (2003a). MO25alpha/beta interact with 
STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the 
cytoplasm. Embo J 22, 5102-5114. 
 
Boudeau, J., Sapkota, G., and Alessi, D.R. (2003b). LKB1, a protein kinase regulating cell 
proliferation and polarity. FEBS Lett 546, 159-165. 
 
Brenman, J.E., and Temple, B.R. (2007). Opinion: alternative views of AMP-activated 
protein kinase. Cell Biochem Biophys 47, 321-331. 
 
Bronner, M., Hertz, R., and Bar-Tana, J. (2004). Kinase-independent transcriptional co-
activation of peroxisome proliferator-activated receptor alpha by AMP-activated 
protein kinase. Biochem J 384, 295-305. 
 
Carling, D., Clarke, P.R., Zammit, V.A., and Hardie, D.G. (1989). Purification and 
characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA 
carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. 
Eur J Biochem 186, 129-136. 
 
Carling, D., Zammit, V.A., and Hardie, D.G. (1987). A common bicyclic protein kinase 
cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. 
FEBS Lett 223, 217-222. 
 
Chuderland, D., Konson, A., and Seger, R. (2008). Identification and characterization of a 
general nuclear translocation signal in signaling proteins. Mol Cell 31, 850-861. 
 
Davies, S.P., Carling, D., and Hardie, D.G. (1989). Tissue distribution of the AMP-activated 
protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, 





Davies, S.P., Hawley, S.A., Woods, A., Carling, D., Haystead, T.A., and Hardie, D.G. 
(1994). Purification of the AMP-activated protein kinase on ATP-gamma-sepharose 
and analysis of its subunit structure. Eur J Biochem 223, 351-357. 
 
Dong, X., Biswas, A., Suel, K.E., Jackson, L.K., Martinez, R., Gu, H., and Chook, Y.M. 
(2009). Structural basis for leucine-rich nuclear export signal recognition by CRM1. 
Nature 458, 1136-1141. 
 
Dorfman, J., and Macara, I.G. (2008). STRAD{alpha} Regulates LKB1 Localization by 
Blocking Access to Importin-{alpha}, and by Association with Crm1 and Exportin-7. 
Mol Biol Cell 19, 1614-1626. 
 
Fornerod, M., Ohno, M., Yoshida, M., and Mattaj, I.W. (1997). CRM1 is an export receptor 
for leucine-rich nuclear export signals. Cell 90, 1051-1060. 
 
Frederick, E.D., Ramos, S.B., and Blackshear, P.J. (2008). A unique C-terminal repeat 
domain maintains the cytosolic localization of the placenta-specific tristetraprolin 
family member ZFP36L3. J Biol Chem 283, 14792-14800. 
 
Gao, F.B., Brenman, J.E., Jan, L.Y., and Jan, Y.N. (1999). Genes regulating dendritic 
outgrowth, branching, and routing in Drosophila. Genes Dev 13, 2549-2561. 
 
Gao, G., Fernandez, C.S., Stapleton, D., Auster, A.S., Widmer, J., Dyck, J.R., Kemp, B.E., 
and Witters, L.A. (1996). Non-catalytic beta- and gamma-subunit isoforms of the 5'-
AMP-activated protein kinase. J Biol Chem 271, 8675-8681. 
 
Gorlich, D., and Kutay, U. (1999). Transport between the cell nucleus and the cytoplasm. 
Annu Rev Cell Dev Biol 15, 607-660. 
 
Hardie, D.G. (2007). AMP-activated/SNF1 protein kinases: conserved guardians of cellular 
energy. Nat Rev Mol Cell Biol 8, 774-785. 
 
Hardie, D.G., Carling, D., and Carlson, M. (1998). The AMP-activated/SNF1 protein kinase 
subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67, 821-855. 
 
Heerklotz, D., Doring, P., Bonzelius, F., Winkelhaus, S., and Nover, L. (2001). The balance 
of nuclear import and export determines the intracellular distribution and function of 
tomato heat stress transcription factor HsfA2. Mol Cell Biol 21, 1759-1768. 
 
Henderson, B.R. (2000). Nuclear-cytoplasmic shuttling of APC regulates beta-catenin 
subcellular localization and turnover. Nat Cell Biol 2, 653-660. 
 
Hong, S.P., and Carlson, M. (2007). Regulation of snf1 protein kinase in response to 





Iseli, T.J., Walter, M., van Denderen, B.J., Katsis, F., Witters, L.A., Kemp, B.E., Michell, 
B.J., and Stapleton, D. (2005). AMP-activated protein kinase beta subunit tethers 
alpha and gamma subunits via its C-terminal sequence (186-270). J Biol Chem 280, 
13395-13400. 
 
Jager, S., Handschin, C., St-Pierre, J., and Spiegelman, B.M. (2007). AMP-activated protein 
kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. 
Proc Natl Acad Sci U S A 104, 12017-12022. 
 
Kodiha, M., Rassi, J.G., Brown, C.M., and Stochaj, U. (2007). Localization of AMP kinase is 
regulated by stress, cell density, and signaling through the MEK-->ERK1/2 pathway. 
Am J Physiol Cell Physiol 293, C1427-1436. 
 
Kutay, U., and Guttinger, S. (2005). Leucine-rich nuclear-export signals: born to be weak. 
Trends Cell Biol 15, 121-124. 
 
La Cour, T., Kiemer, L., Molgaard, A., Gupta, R., Skriver, K., and Brunak, S. (2004). 
Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel 
17, 527-536. 
 
Lamia, K.A., Sachdeva, U.M., DiTacchio, L., Williams, E.C., Alvarez, J.G., Egan, D.F., 
Vasquez, D.S., Juguilon, H., Panda, S., Shaw, R.J., Thompson, C.B., and Evans, R.M. 
(2009). AMPK regulates the circadian clock by cryptochrome phosphorylation and 
degradation. Science 326, 437-440. 
 
Leff, T. (2003). AMP-activated protein kinase regulates gene expression by direct 
phosphorylation of nuclear proteins. Biochem Soc Trans 31, 224-227. 
 
Leung, S.W., Harreman, M.T., Hodel, M.R., Hodel, A.E., and Corbett, A.H. (2003). 
Dissection of the karyopherin alpha nuclear localization signal (NLS)-binding 
groove: functional requirements for NLS binding. J Biol Chem 278, 41947-41953. 
 
Lizcano, J.M., Goransson, O., Toth, R., Deak, M., Morrice, N.A., Boudeau, J., Hawley, S.A., 
Udd, L., Makela, T.P., Hardie, D.G., and Alessi, D.R. (2004). LKB1 is a master 
kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. 
Embo J 23, 833-843. 
 
Matsubayashi, Y., Fukuda, M., and Nishida, E. (2001). Evidence for existence of a nuclear 
pore complex-mediated, cytosol-independent pathway of nuclear translocation of 
ERK MAP kinase in permeabilized cells. J Biol Chem 276, 41755-41760. 
 
McGee, S.L., Howlett, K.F., Starkie, R.L., Cameron-Smith, D., Kemp, B.E., and Hargreaves, 
M. (2003). Exercise increases nuclear AMPK alpha2 in human skeletal muscle. 





Medina, P.M., Swick, L.L., Andersen, R., Blalock, Z., and Brenman, J.E. (2006). A novel 
forward genetic screen for identifying mutations affecting larval neuronal dendrite 
development in Drosophila melanogaster. Genetics 172, 2325-2335. 
 
Mirouse, V., Swick, L.L., Kazgan, N., St Johnston, D., and Brenman, J.E. (2007). LKB1 and 
AMPK maintain epithelial cell polarity under energetic stress. J Cell Biol 177, 387-
392. 
 
Narkar, V.A., Downes, M., Yu, R.T., Embler, E., Wang, Y.X., Banayo, E., Mihaylova, 
M.M., Nelson, M.C., Zou, Y., Juguilon, H., Kang, H., Shaw, R.J., and Evans, R.M. 
(2008). AMPK and PPARdelta agonists are exercise mimetics. Cell 134, 405-415. 
 
Nezu, J., Oku, A., and Shimane, M. (1999). Loss of cytoplasmic retention ability of mutant 
LKB1 found in Peutz-Jeghers syndrome patients. Biochem Biophys Res Commun 
261, 750-755. 
 
Rosin-Arbesfeld, R., Townsley, F., and Bienz, M. (2000). The APC tumour suppressor has a 
nuclear export function. Nature 406, 1009-1012. 
 
Salt, I., Celler, J.W., Hawley, S.A., Prescott, A., Woods, A., Carling, D., and Hardie, D.G. 
(1998). AMP-activated protein kinase: greater AMP dependence, and preferential 
nuclear localization, of complexes containing the alpha2 isoform. Biochem J 334 ( Pt 
1), 177-187. 
 
Stapleton, D., Gao, G., Michell, B.J., Widmer, J., Mitchelhill, K., Teh, T., House, C.M., 
Witters, L.A., and Kemp, B.E. (1994). Mammalian 5'-AMP-activated protein kinase 
non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein 
kinase. J Biol Chem 269, 29343-29346. 
 
Strom, A.C., and Weis, K. (2001). Importin-beta-like nuclear transport receptors. Genome 
Biol 2, REVIEWS3008. 
 
Suzuki, A., Okamoto, S., Lee, S., Saito, K., Shiuchi, T., and Minokoshi, Y. (2007). Leptin 
stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha 
gene expression in mouse C2C12 myoblasts by changing the subcellular localization 
of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol 27, 4317-4327. 
 
Vincent, O., Townley, R., Kuchin, S., and Carlson, M. (2001). Subcellular localization of the 
Snf1 kinase is regulated by specific beta subunits and a novel glucose signaling 
mechanism. Genes Dev 15, 1104-1114. 
 
Warden, S.M., Richardson, C., O'Donnell, J., Jr., Stapleton, D., Kemp, B.E., and Witters, 
L.A. (2001). Post-translational modifications of the beta-1 subunit of AMP-activated 






Weis, K. (2003). Regulating access to the genome: nucleocytoplasmic transport throughout 
the cell cycle. Cell 112, 441-451. 
 
Xiao, B., Heath, R., Saiu, P., Leiper, F.C., Leone, P., Jing, C., Walker, P.A., Haire, L., 
Eccleston, J.F., Davis, C.T., Martin, S.R., Carling, D., and Gamblin, S.J. (2007). 
Structural basis for AMP binding to mammalian AMP-activated protein kinase. 
Nature 449, 496-500. 
 
Xie, Z., Dong, Y., Zhang, J., Scholz, R., Neumann, D., and Zou, M.H. (2009). Identification 
of the serine 307 of LKB1 as a novel phosphorylation site essential for its 
nucleocytoplasmic transport and endothelial cell angiogenesis. Mol Cell Biol 29, 
3582-3596. 
 
Xu, L., and Massague, J. (2004). Nucleocytoplasmic shuttling of signal transducers. Nat Rev 
Mol Cell Biol 5, 209-219. 
 
Yasuhara, N., Oka, M., and Yoneda, Y. (2009). The role of the nuclear transport system in 
cell differentiation. Semin Cell Dev Biol 20, 590-599. 
 
Zhang, F., White, R.L., and Neufeld, K.L. (2000). Phosphorylation near nuclear localization 
signal regulates nuclear import of adenomatous polyposis coli protein. Proc Natl 









Summary and Future Directions 
 
AMPK and cell polarity. Although AMPK is a cellular energy sensor, its primary 
sequence is highly similar to well-known polarity genes, such as SAD kinase and par-1. 
Recent cell culture studies suggest AMPK has a role in polarization of MDCK cells (Zhang 
et al., 2006). This raises the question as to whether AMPK has other roles besides sensing the 
cellular energy level. 
The other reason to suggest AMPK has a role in cell polarity is due to LKB1, an 
AMPK activator, itself being an essential polarity gene. That being said, LKB1 regulates par-
1 polarity gene and there are claims LKB1 mediates its cell polarity function through par-1 
and cellular energy level control through AMPK. With our data, we have shown that AMPK 
has a role in epithelial cell polarity. But we do not know the signaling mechanism of this 
effect. A second article after our initial publication on AMPK’s role in cell polarity claimed 
AMPK mediates cell polarity through the phosphorylation of non-muscle myosin regulatory 
light chain (MRLC) protein (Lee et al., 2007). The authors demonstrated that a constitutively 
active copy of MRLC rescues the loss of polarity phenotype due to loss of AMPK activity 
both in fruit flies and in mammalian cell culture studies. Preliminary data from our lab 
suggests that loss of MRLC in neurons shows a similar phenotype to loss of AMPK (data not 
shown). 
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In addition, since it is already known that LKB1 has a cell polarity effect through par-
1, it is essential to determine whether a loss of par-1 has a similar effect on epithelial-like 
tissues in post-developmental stages. It is also essential to over-express an active copy of 
par-1 in an lkb1 mutant background and determine if the lkb1 null cell phenotype is rescued. 
AMPK, metabolism and behavior. Since we were the first lab to identify AMPKα 
mutations in fruit flies and since mammals have multiple α subunits, i.e., redundancy, it is 
wise to assess the effect of loss of AMPK on the whole animal. However, it is essential to 
keep in mind that AMPK has diverse actions in different tissues and organs. That is why it is 
important to express an AMPK dominant-negative in different tissues and determine its 
effects on different organs. 
One tissue we have determined the effect of loss of AMPK either by an AMPKα null 
mutant or a dominant-negative is the liver-like oenocytes. Oenocytes are 4-6 cells that exist 
in every segment of the larvae and adults. They are responsible for the translocation of fatty 
acids from fat bodies to them and so they can metabolize those lipids and transport to the 
neighboring cells (Gutierrez et al., 2007). As we show in Chapter III, Figure 3-7, oenocytes 
accumulate neutral lipids when the larvae are starved. In AMPKα null mutant larvae, they 
accumulate neutral lipids without starvation. This means under non-starvation conditions, our 
AMPKα null mutants display a starvation phenotype. At the same time, we do not know 
whether they are aberrantly processing the lipids in the oenocytes or if the lipids are 
excessively accumulated in the oenocytes in our AMPKα null mutants. The total triglyceride 
levels of the AMPK mutants are also low even though they are hyperphagic. So, how can 
they be both hyperphagic and have less stored lipid? The most likely hypothesis is they are 
incapable of using their stored triglycerides in the absence of AMPK, i.e., their capability of 
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storing, processing and breaking down fatty acids is reduced without AMPK. Another 
hypothesis is a loss of AMPK in the gut cells leads to reduced nutrient uptake due to 
impaired peristaltic activity and this explains the larvae being hyperphagic and low stored 
lipids at the same time (Bland et al., 2010).  
AMPK subcellular localization. As mentioned in Chapter IV, AMPK sub-cellular 
localization, nucleus vs. cytoplasm, is essential for AMPK’s access to its downstream and 
upstream targets. That being said, we have not seen any effects on direct nuclear targets of 
AMPK in the literature up to this date. In our hands, p-AMPK localizes mostly in the 
cytoplasm in fruit flies cells (Mirouse et al., 2007). There are other groups that have shown 
AMPK is localized to the nucleus under stress or under adipose-derived hormone, leptin, 
treatment (Kodiha et al., 2007) (Suzuki et al., 2007). In our hands, we were unable repeat any 
of these experiments. Neither heat shocking nor Leptomycin B treatment of HEK293 or 
HeLa cells followed by fractionation of endogenous proteins resulted in any increased 
nuclear localization of either AMPKα or AMPKβ. But this could very well be due a 
difference in fractionation efficiency or technique between us and those authors. Leptin 
treatment in HEK293 cells did not change the localization of AMPKα, but this might be due 
to HEK293 cell’s insensitivity to leptin treatment.  
 Trying to look for a change in the phosphorylation status of downstream targets of 
AMPK in HEK293 cells, we transfected with our constructs (AMPKα wild-type, 
AMPKαΔC, AMPKαL,L→A,A, or AMPKα Dominant-negative) but did not find any 
significant results either. We were checking the p-ACC level as an indicator of the activity of 
AMPK. Since AMPK has to be a complex to be functional, we went ahead and transfected 
cells not only with AMPKα alone but concomitantly with β and γ. We then again checked the 
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p-ACC level and did not see any significant difference between non-transfected and 
transfected cells. We then thought maybe we should stress these cells after transfection by 
fully starving them and determine whether the transfected cells showed any difference in p-
ACC level. In addition, we treated some of the transfected cells with the AMPK activator 
AICAR with or without starvation and measured the difference in p-ACC levels. None of the 
above conditions showed any change in p-ACC level. Then we realized both in flies and in 
cell culture, AMPK activity is regulated when we over-express a wild-type or mutant version 
of AMPK. For instance, when we over-express a wild-type copy of AMPKα in cells, the 
endogenous AMPKα phospho-level will drop only slightly since the exogenous construct can 
also be phosphorylated (data not shown). On the other hand, when we overexpress a 
Dominant Negative copy of AMPKα both in flies and cell culture, the endogenous AMPKα 
phosphorylation level increases. So we conclude there is an internal regulation of total 
functional AMPK and its activity level in the cells in vitro and in vivo. Unless we have 
AMPKα mutant cells, we will not be able to express different constructs and observe a 
change in p-ACC levels or other downstream targets. Currently, we have AMPKα1 and α2 
subunit null mouse embryonic fibroblast (MEF) cells in our lab. These cells have a very low 
p-ACC level as we have published before (Williams et al., 2009). Our efforts to transfect 
MEF-KO cells were unsuccessful since MEF-KO cells proved to have a very low rate of 
transfection. We might consider trying to make stable cell lines expressing constructs of 
AMPKα. 
During this time, we have also decided to use shRNA to downregulate the 
endogenous AMPKα in HEK293 cells and to then over-express the AMPK wild-type or 
mutant constructs to observe their effects on p-ACC levels. Normally the shRNA would 
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knock down the over-expression constructs since the constructs are also translating AMPKα. 
However, we will use a shRNA that is specific to only human AMPKα and then over-express 
the rat AMPKα wild-type and mutant constructs to observe the effect on p-ACC levels. 
Through this method, we hope to show a biological tie to change of localization of AMPK 
using in vitro studies. We cannot repeat some of these experiments in fruit flies since we do 
not have an antibody that recognizes Drosophila p-ACC levels. 
New nuclear target of AMPK. During our studies, a new study emerged claiming a 
new nuclear target of AMPK. The authors claim AMPK regulates the Circadian Clock by 
translocating to the nucleus during the day and phosphorylating, and thereby leading to the 
degradation of, CRY1. This will then cause the expression of Clock-controlled genes (Lamia 
et al., 2009). They have done fractionation studies from mouse liver nucleus. We have 
decided to do the same experiments (mentioned above in our shRNA endogenous AMPKα 
and over-expression of wild-type or mutant copy of AMPKα experiments) and check the 
total level of CRY1 in addition to looking at p-ACC levels. We will overexpress a Flag-
tagged version of CRY1 and check the total levels of CRY1 when expressing different 
constructs of AMPKα. We will then use cycloheximide, an inhibitor of protein biosynthesis, 
and observe the total level of CRY1 by over-expression of AMPKα constructs. 
 Fractionation of AMPK complex.  During our studies, one of the questions we 
asked was whether AMPKα goes into nucleus as a heterotrimeric complex attached to the β 
and γ subunits, or if it enters alone? We have immunoprecipitation experiments (Chapter IV; 
Figures 4- 8) of the over-expression of the α, β and γ subunits in HEK293 cells where α is 
either wild-type or an LL->AA mutation. In that experiment, even the nuclear AMPKα is still 
bound to the β and γ subunits 80-90% of the time indicating AMPK enters the nucleus as a 
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heterotrimer. We also have immunostaining experiments that show when AMPKα is in the 
nucleus, the regulatory subunits tend to localize with it. But we still want to over-express 
these constructs and then fractionate nuclear proteins and determine if AMPKα, β and γ are 
together in the nucleus. Despite our efforts to fractionate the over-expression proteins, we 
were unable to successfully complete these experiments. This was not due to any intrinsic 
property of AMPK itself since our control fractionation of over-expressed GFP-SV40NLS, a 
construct which normally localizes to the nucleus, was also not successful. We noticed as 
soon as the cells were broken, the nuclear GFP began to leak out of the nucleus within 
minutes.  
 Restoring the cytoplasmic localization of AMPKα in Drosophila. As we have 
shown in Chapter IV, cytoplasmic localization of truncated AMPKαΔC538 can be rescued by 
attaching a known NES sequence at the C-terminus end. We will generate transgenic flies 
expressing the same construct and check (i) localization and phosphorylation level of that 
construct. If that construct localizes to the cytoplasm and can be phosphorylated, then we will 
know the phosphorylation of AMPK takes place in the cytosol. (ii)We will also cross that 
line to an AMPKα mutant background and see whether it will rescue the lethality of AMPKα 
null flies.  
Determining the mechanism of the loss of AMPKα phenotype in sensory 
neurons. As we have shown in Chapter II, the AMPKα mutant phenotype causes a 
morphological defect in the fruit fly sensory neurons. The dendritic enlargement phenotype 
only happens in dendrites whereas the axons and the filopodia seem normal. We observe a 
similar phenotype with over-expression of the dominant-negative, as shown in Chapter III. 
We wanted to check whether any mutants of the regulatory subunits of AMPK, the β and γ 
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subunits, exist in the Flybase. There was no Drosophila β subunit mutation at hand until 
recently and so we were unable to check the sensory neuron phenotype in those flies. On the 
other hand, we have found multiple P-element translocation lines in Flybase. P-elements are 
transposable elements that are randomly inserted into the fly genome and produced to 
randomly disrupt genes (Spradling et al., 1995). Their localization in the genome is 
confirmed by sequencing from each end of the transposable element. We have chosen around 
nine of these P-elements that are mapped to Drosophila AMPKγ subunit, the Snf4 gene. We 
thought some of these P-elements might cause a null genotype of the Snf4 gene. We chose 
the ones that are partly or wholly located in the exons of Snf4. Five of these P-elements had a 
dendritic enlargement phenotype identical to the AMPKα loss of function, but less severe 
(Fig. 5-1). Later on, we did rescue the Snf4 mutant phenotype and its lethality by 
overexpressing a wild-type copy of Snf4 in these neurons (data not shown).  
This above data shows that the phenotype that we see in these neurons is due to loss 
of AMPK activity. There is another group (Tschape et al., 2002) claiming loss of Snf4 in 
Drosophila causes progressive neurodegeneration and neuronal cell death. Sections from the 
Snf4 mutant fly brain showed accumulation of vacuoles. We suspected the phenotype that we 
see in fly sensory neurons is due to some vacuolar defect or some endocytotic pathway 
defect. We ordered mutations in genes that are in the endocytotic or autophagy pathway. We 
checked whether any of them with or without the AMPKα mutant would show a similar 
phenotype to the loss of AMPK phenotype. None of the mutants or the over-expression of 










Figure 5-1. Both dAMPK α and dAMPK γ mutants lead to enlarged dendrite membrane 
swellings/domains. Drosophila dendritic arborization (da) neurons (A), and mutant dAMPK 
α (B) and a P element allele of dAMPK γ (C). Both mutants show similar dendritic 
phenotypes, stronger with dAMPKα mutant. Arrows point at striking membrane 








When we over-express a UAS- Dominant Negative copy of AMPKα under an 
ubiquitous Gal4 line and incubate them in higher temperature (29°C), they will not survive 
till adulthood. When we overexpress AMPKα wild-type copy, it will rescue the lethality 
phenotype whereas over-expression of UAS-GFP does not rescue the lethality. Then, we 
ordered UAS lines of candidate genes that are either involved in the AMPK signaling 
pathway or have a role in endocytotic machinery. None of the overexpression of candidate 
genes gave us any rescued flies at higher temperature.  
That is why we have decided to design a screen to identify and characterize novel 
downstream and upstream regulators of AMPK. The lab is currently working on an EMS 
mutagenesis screen using either shRNA of AMPKα or Dominant negative AMPKα as their 
starting flies where the EMS mutation will suppress the lethality of these fly lines. It is hoped 
new modifier screens will help elucidate novel components of AMPK signaling to help 
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